Exact Mass: 416.3079

Exact Mass Matches: 416.3079

Found 500 metabolites which its exact mass value is equals to given mass value 416.3079, within given mass tolerance error 0.05 dalton. Try search metabolite list with more accurate mass tolerance error 0.01 dalton.

Sarsasapogenin

(2aR,4S,5S,6aS,6bS,8aS,8bR,9S,10R,11aS,12aS,12bR)-5,6a,8a,9-tetramethyldocosahydrospiro[naphtho[2,1:4,5]indeno[2,1-b]furan-10,2-pyran]-4-ol

C27H44O3 (416.329)


(25S)-5beta-spirostan-3beta-ol is a sapogenin. Sarsasapogenin is a natural product found in Yucca gloriosa, Narthecium ossifragum, and other organisms with data available. Constituent of Radix sarsaparilla (sarsaparilla root). Sarsasapogenin is found in asparagus, herbs and spices, and fenugreek. Sarsasapogenin is found in asparagus. Sarsasapogenin is a constituent of Radix sarsaparilla (sarsaparilla root) C274 - Antineoplastic Agent > C1931 - Antineoplastic Plant Product > C823 - Saponin C1907 - Drug, Natural Product Sarsasapogenin is a sapogenin from the Chinese medical herb Anemarrhena asphodeloides Bunge, with antidiabetic, anti-oxidative, anticancer and anti-inflamatory activities. Sarsasapogenin is a sapogenin from the Chinese medical herb Anemarrhena asphodeloides Bunge, with antidiabetic, anti-oxidative, anticancer and anti-inflamatory activities.

   

tigogenin

(2aS,2R,4S,5R,6aS,6bS,8aS,8bR,9S,11aS,12aS,12bR)-5,6a,8a,9-Tetramethyldocosahydrospiro[naphtho[2,1:4,5]indeno[2,1-b]furan-10,2-pyran]-4-ol

C27H44O3 (416.329)


Tigogenin is a widely used steroidal sapogenin isolated from several plant species and used for synthesizing steroid drugs. It has a role as a gout suppressant and a plant metabolite. Tigogenin is a natural product found in Cordyline australis, Yucca gloriosa, and other organisms with data available. A widely used steroidal sapogenin isolated from several plant species and used for synthesizing steroid drugs. Tigogenin, also known as sarsasapogenin, (3beta,5alpha,25s)-isomer or smilagenin, is a member of the class of compounds known as triterpenoids. Triterpenoids are terpene molecules containing six isoprene units. Thus, tigogenin is considered to be a sterol lipid molecule. Tigogenin is practically insoluble (in water) and an extremely weak acidic compound (based on its pKa). Tigogenin can be found in fenugreek, which makes tigogenin a potential biomarker for the consumption of this food product. Tigogenin, one of steroidal sapogenins, is widely used for synthesizing steroid agents. Tigogenin inhibits adipocytic differentiation and induces osteoblastic differentiation in mouse bone marrow stromal cells[1]. Tigogenin, one of steroidal sapogenins, is widely used for synthesizing steroid agents. Tigogenin inhibits adipocytic differentiation and induces osteoblastic differentiation in mouse bone marrow stromal cells[1].

   

Smilagenin

(1R,2R,2S,4S,5R,7S,8R,9S,12S,13S,16S,18R)-5,7,9,13-tetramethyl-5-oxaspiro[oxane-2,6-pentacyclo[10.8.0.0²,⁹.0⁴,⁸.0¹³,¹⁸]icosane]-16-ol

C27H44O3 (416.329)


(25R)-5beta-spirostan-3beta-ol is an oxaspiro compound that is(5beta,25R)-spirostan substituted by a beta-hydroxy group at position 3. It has a role as an antineoplastic agent and a metabolite. It is an oxaspiro compound, a 3beta-hydroxy steroid, an organic heterohexacyclic compound and a sapogenin. It derives from a hydride of a (25R)-5beta-spirostan. Smilagenin is a novel non-peptide, orally bioavailable neurotrophic factor inducer that readily reverses free radical neurotoxicity produced by 1-ethyl-4- phenylpyridium (MPP+) in dopaminergic neurones and reverses the decrease of neuronal growth factors and dopamine receptors in the brain. Pre-clinical work with smilagenin showed it to be neuroprotective against betya-amyloid and glutamate damage which contributes to Alzheimers disease and reverses the changes in the area of the brain involved in Parkinson’s disease. P58 is a protein synthesis stimulant acts by restoring levels of proteins that are altered in the ageing brain, reversing the loss of nerve receptors in the ageing brain and potentially allowing for the regrowth of neural connections. P58 therefore provides a totally novel mode of action with potential importance for diseases associated with ageing of the brain. P58 is one of a family of phytochemicals isolated from traditional treatments for the elderly that have previously been shown to offer significant benefit in the treatment of senile dementia. Smilagenin is a natural product found in Yucca gloriosa, Yucca aloifolia, and other organisms with data available. Constituent of Jamaica sarsaparilla (Smilax ornata). Smilagenin is found in herbs and spices and fenugreek. Smilagenin is found in fenugreek. Smilagenin is a constituent of Jamaica sarsaparilla (Smilax ornata) An oxaspiro compound that is(5beta,25R)-spirostan substituted by a beta-hydroxy group at position 3. C78276 - Agent Affecting Digestive System or Metabolism > C29711 - Anti-diabetic Agent Smilagenin (SMI) is a small-molecule steroidal sapogenin from Anemarrhena asphodeloides and Pelargonium hortorum widely used in traditional Chinese medicine for treating chronic neurodegeneration diseases[1]. Smilagenin (SMI) improves memory of aged rats by increasing the muscarinic receptor subtype 1 (M1)-receptor density[2]. Smilagenin (SMI) attenuates Aβ(25-35)-induced neurodegenerationvia stimulating the gene expression of brain-derived neurotrophic factor, may represents a novel therapeutic strategy for AD[3]. Smilagenin (SMI) is a small-molecule steroidal sapogenin from Anemarrhena asphodeloides and Pelargonium hortorum widely used in traditional Chinese medicine for treating chronic neurodegeneration diseases[1]. Smilagenin (SMI) improves memory of aged rats by increasing the muscarinic receptor subtype 1 (M1)-receptor density[2]. Smilagenin (SMI) attenuates Aβ(25-35)-induced neurodegenerationvia stimulating the gene expression of brain-derived neurotrophic factor, may represents a novel therapeutic strategy for AD[3]. Smilagenin (SMI) is a small-molecule steroidal sapogenin from Anemarrhena asphodeloides and Pelargonium hortorum widely used in traditional Chinese medicine for treating chronic neurodegeneration diseases[1]. Smilagenin (SMI) improves memory of aged rats by increasing the muscarinic receptor subtype 1 (M1)-receptor density[2]. Smilagenin (SMI) attenuates Aβ(25-35)-induced neurodegenerationvia stimulating the gene expression of brain-derived neurotrophic factor, may represents a novel therapeutic strategy for AD[3].

   

beta-Carotinal

2,4,6,8,10,12,14,16-Heptadecaoctaenal, 2,6,11,15-tetramethyl-17-(2,6,6-trimethyl-1-cyclohexen-1-yl)-, (2E,4E,6E,8E,10E,12E,14E,16E)-

C30H40O (416.3079)


8-apo-beta,psi-caroten-8-al is an apo carotenoid triterpenoid compound arising from oxidative degradation of the beta,beta-carotene skeleton at the 8-position. It is an enal and an apo carotenoid triterpenoid. Apocarotenal is a natural product found in Dracaena draco, Palisota barteri, and other organisms with data available. Constituent of orange peel, spinach, marigolds and egg yolks. Colour additive. beta-Carotinal is found in many foods, some of which are eggs, green vegetables, sweet orange, and citrus. beta-Carotinal is found in citrus. beta-Carotinal is a constituent of orange peel, spinach, marigolds and egg yolks. Colour additive. D020011 - Protective Agents > D000975 - Antioxidants > D002338 - Carotenoids β-Apo-8'-carotenal (Apocarotenal), a provitamin A carotenoid, is an inducer of CYPlA1 and CYPlA2 in rat. β-Apo-8'-carotenal is present in many fruits and vegetables[1]. β-Apo-8'-carotenal (Apocarotenal), a provitamin A carotenoid, is an inducer of CYPlA1 and CYPlA2 in rat. β-Apo-8'-carotenal is present in many fruits and vegetables[1].

   

Calcitriol

(1R,3S,5Z)-5-{2-[(1R,3aS,4E,7aR)-1-[(2R)-6-hydroxy-6-methylheptan-2-yl]-7a-methyl-octahydro-1H-inden-4-ylidene]ethylidene}-4-methylidenecyclohexane-1,3-diol

C27H44O3 (416.329)


The physiologically active form of vitamin D. It is formed primarily in the kidney by enzymatic hydroxylation of 25-hydroxycholecalciferol (calcifediol). Its production is stimulated by low blood calcium levels and parathyroid hormone. Calcitriol increases intestinal absorption of calcium and phosphorus, and in concert with parathyroid hormone increases bone resorption.--PubChem [HMDB] The physiologically active form of vitamin D. It is formed primarily in the kidney by enzymatic hydroxylation of 25-hydroxycholecalciferol (calcifediol). Its production is stimulated by low blood calcium levels and parathyroid hormone. Calcitriol increases intestinal absorption of calcium and phosphorus, and in concert with parathyroid hormone increases bone resorption.--PubChem. A - Alimentary tract and metabolism > A11 - Vitamins > A11C - Vitamin a and d, incl. combinations of the two > A11CC - Vitamin d and analogues D002317 - Cardiovascular Agents > D014662 - Vasoconstrictor Agents > D002120 - Calcium Channel Agonists COVID info from clinicaltrial, clinicaltrials, clinical trial, clinical trials, COVID-19 Disease Map C274 - Antineoplastic Agent > C2122 - Cell Differentiating Agent > C1934 - Differentiation Inducer D018977 - Micronutrients > D014815 - Vitamins > D004100 - Dihydroxycholecalciferols D - Dermatologicals > D05 - Antipsoriatics > D05A - Antipsoriatics for topical use D018977 - Micronutrients > D014815 - Vitamins > D006887 - Hydroxycholecalciferols D000077264 - Calcium-Regulating Hormones and Agents D050071 - Bone Density Conservation Agents D049990 - Membrane Transport Modulators Corona-virus Coronavirus SARS-CoV-2 COVID-19 SARS-CoV COVID19 SARS2 SARS

   

24,25-Dihydroxyvitamin D

(6R)-6-[(1R,3aS,4E,7aR)-4-{2-[(1Z,5R)-5-hydroxy-2-methylidenecyclohexylidene]ethylidene}-7a-methyl-octahydro-1H-inden-1-yl]-2-methylheptane-2,3-diol

C27H44O3 (416.329)


24,25-Dihydroxyvitamin D (24R,25(OH)2D3) circulates in blood at concentrations about 1000 times higher than 1alpha,25(OH)2D3. 24-Hydroxylase is present in the proximal convoluted tubule cells of the kidney and in virtual all target cells of 1alpha,25(OH)2D3. Interestingly, 1alpha,25(OH)2D3 is a very strong inducer of 24-hydroxylase activity and 24R,25(OH)2D3 formation. Also parathyroid hormone (PTH) regulates 24-hydroxylase activity but in a tissue specific manner, i.e. inhibitory in the kidney while a synergistic effect together with 1alpha,25(OH)2D3 is observed in osteoblasts. Generally, 24-hydroxylation has been considered the first step in the degradation pathway of 1alpha,25(OH)2D3 and 25-(OH)D3. However, through the past decades data have accumulated that 24R,25(OH)2D3 is not merely a degradation product but has effects on its own. Classic studies have demonstrated the significance of 24R,25(OH)2D3 for normal chicken egg hatchability and calcium and phosphorus homeostasis. More recently it became apparent that 24R,25(OH)2D3 also has distinct effects on cartilage in particular the resting zone cells. 24R,25(OH)2D3 stimulates osteocalcin synthesis in human osteoblasts. 24R,25(OH)2D3 plays a role in bone metabolism but that it acts in concert with 1alpha,25(OH)2D3 to obtain an optimal effect. (PMID: 11179746). D018977 - Micronutrients > D014815 - Vitamins > D004100 - Dihydroxycholecalciferols D018977 - Micronutrients > D014815 - Vitamins > D006887 - Hydroxycholecalciferols D000077264 - Calcium-Regulating Hormones and Agents D050071 - Bone Density Conservation Agents

   

Paricalcitol

(1R,3R)-5-{2-[(1R,3aS,4E,7aR)-1-[(2R,3E,5S)-6-hydroxy-5,6-dimethylhept-3-en-2-yl]-7a-methyl-octahydro-1H-inden-4-ylidene]ethylidene}cyclohexane-1,3-diol

C27H44O3 (416.329)


Paricalcitol is only found in individuals that have used or taken this drug. It is a synthetic vitamin D analog. Paricalcitol has been used to reduce parathyroid hormone levels. Paricalcitol is indicated for the prevention and treatment of secondary hyperparathyroidism associated with chronic renal failure.Paricalcitol is biologically active vitamin D analog of calcitriol with modifications to the side chain (D2) and the A (19-nor) ring. Preclinical andin vitro studies have demonstrated that paricalcitols biological actions are mediated through binding of the VDR, which results in the selective activation of vitamin D responsive pathways. Vitamin D and paricalcitol have been shown to reduce parathyroid hormone levels by inhibiting PTH synthesis and secretion. H - Systemic hormonal preparations, excl. sex hormones and insulins > H05 - Calcium homeostasis > H05B - Anti-parathyroid agents D018977 - Micronutrients > D014815 - Vitamins > D004872 - Ergocalciferols

   

Probolin

Methandriol dipropionate

C26H40O4 (416.2926)


Same as: D08197

   

5,6-24(S),25-Diepoxycholesterol

5,6-24(S),25-Diepoxycholesterol; (24S,25)-Epoxycholesterol alpha-epoxide

C27H44O3 (416.329)


   

ST 27:2;O3

3beta,5beta-Ketodiol; 2,22,25-Trideoxyecdysone; 3beta,14alpha-Dihydroxy-5beta-cholest-7-en-6-one

C27H44O3 (416.329)


   

7alpha,24-dihydroxycholest-4-en-3-one

(1S,2R,9R,10S,11S,14R,15R)-9-hydroxy-14-[(2R)-5-hydroxy-6-methylheptan-2-yl]-2,15-dimethyltetracyclo[8.7.0.0^{2,7}.0^{11,15}]heptadec-6-en-5-one

C27H44O3 (416.329)


7alpha,24-dihydroxycholest-4-en-3-one is also known as 4-Cholesten-7alpha,24-diol-3-one. 7alpha,24-dihydroxycholest-4-en-3-one is considered to be practically insoluble (in water) and relatively neutral. 7alpha,24-dihydroxycholest-4-en-3-one is a bile acid lipid molecule

   

7alpha,25-Dihydroxy-4-cholesten-3-one

(1S,2R,9R,10S,11S,14R,15R)-9-hydroxy-14-[(2R)-6-hydroxy-6-methylheptan-2-yl]-2,15-dimethyltetracyclo[8.7.0.0²,⁷.0¹¹,¹⁵]heptadec-6-en-5-one

C27H44O3 (416.329)


This compound belongs to the family of Cholesterols and Derivatives. These are compounds containing an hydroxylated chloestane moeity.

   

3beta-hydroxy-5-cholestenoate

(2R,6R)-6-[(1S,2R,5S,10S,11S,14R,15R)-5-hydroxy-2,15-dimethyltetracyclo[8.7.0.0^{2,7}.0^{11,15}]heptadec-7-en-14-yl]-2-methylheptanoic acid

C27H44O3 (416.329)


3beta-Hydroxy-5-cholestenoic acid (CAS: 6561-58-6) belongs to the class of organic compounds known as monohydroxy bile acids, alcohols, and derivatives. These are bile acids, alcohols or any of their derivatives bearing a hydroxyl group. 3beta-Hydroxy-5-cholestenoic acid is found in the primary bile acid biosynthesis pathway. 3beta-Hydroxy-5-cholestenoic acid is created from cholest-5-ene-3 beta,26-diol through the action of CYP27A (EC 1.14.13.15). 3beta-Hydroxy-5-cholestenoic acid is then converted into 3beta,7alpha-dihydroxy-5-cholestenoic acid by the action of CYP7B (EC 1.14.13.100). 3beta-Hydroxy-5-cholestenoic acid was identified as one of forty plasma metabolites that could be used to predict gut microbiome Shannon diversity (PMID: 31477923). Shannon diversity is a metric that summarizes both species abundance and evenness, and it has been suggested as a marker for microbiome health.

   

7 alpha,26-Dihydroxy-4-cholesten-3-one

(2R,9R,15R)-9-hydroxy-14-[(2R)-7-hydroxy-6-methylheptan-2-yl]-2,15-dimethyltetracyclo[8.7.0.0²,⁷.0¹¹,¹⁵]heptadec-6-en-5-one

C27H44O3 (416.329)


7 alpha,26-Dihydroxy-4-cholesten-3-one is involved in primary bile acid biosynthesis. 7 alpha,26-Dihydroxy-4-cholesten-3-one is produced from 7 alpha,27-Dihydroxycholesterol through the action of HSD3B7 (EC:1.1.1.181). 7 alpha,26-Dihydroxy-4-cholesten-3-one can then be converted to 7 alpha-Hydroxy-3-oxo-4-cholestenoate by CYP27A (EC:1.14.13.15). 7 alpha,26-Dihydroxy-4-cholesten-3-one is involved in primary bile acid biosynthesis.

   

7α,12α-dihydroxycholest-4-en-3-one

7α,12α-Dihydroxycholest-4-en-3-one

C27H44O3 (416.329)


   

Istamycin A3

2-Formimidoylistamycin B

C18H36N6O5 (416.2747)


   

Pseudotigogenin

(25R)-5alpha-Furost-20(22)-ene-3beta,26-diol

C27H44O3 (416.329)


   

4,4-Diaponeurosporen-4-al

2,6,10,15,19,23-hexamethyltetracosa-2E,4E,6E,8E,10E,12E,14E,16E,18E,22-decaenal

C30H40O (416.3079)


   

7a,12a-Dihydroxy-cholestene-3-one

(1S,2R,9R,10R,11S,14R,15R,16S)-9,16-dihydroxy-2,15-dimethyl-14-[(2R)-6-methylheptan-2-yl]tetracyclo[8.7.0.0²,⁷.0¹¹,¹⁵]heptadec-3-en-5-one

C27H44O3 (416.329)


7a,12a-Dihydroxy-cholestene-3-one is an intermediate in bile acid synthesis; is considerably higher in patients with cerebrotendinous xanthomatosis (CTX) than in the normal liver. (PMID 7017048) [HMDB] 7a,12a-Dihydroxy-cholestene-3-one is an intermediate in bile acid synthesis; is considerably higher in patients with cerebrotendinous xanthomatosis (CTX) than in the normal liver. (PMID 7017048).

   
   

Pseudosmilagenin

(25R)-5beta-Furost-20(22)-ene-3beta,26-diol

C27H44O3 (416.329)


   

Pseudosarsasapogenin

(25S)-5beta-Furost-20(22)-ene-3beta,26-diol

C27H44O3 (416.329)


   

Tacalcitol

(24R)-1α,24-dihydroxyvitamin D3 / (24R)-1α,24-dihydroxycholecalciferol

C27H44O3 (416.329)


D018977 - Micronutrients > D014815 - Vitamins > D004100 - Dihydroxycholecalciferols D - Dermatologicals > D05 - Antipsoriatics > D05A - Antipsoriatics for topical use D018977 - Micronutrients > D014815 - Vitamins > D006887 - Hydroxycholecalciferols D000893 - Anti-Inflammatory Agents D003879 - Dermatologic Agents Same as: D08554

   

7 alpha,24-Dihydroxy-4-cholesten-3-one

(2R,9R,15R)-9-hydroxy-14-[(2R)-5-hydroxy-6-methylheptan-2-yl]-2,15-dimethyltetracyclo[8.7.0.0²,⁷.0¹¹,¹⁵]heptadec-6-en-5-one

C27H44O3 (416.329)


7 alpha,24-Dihydroxy-4-cholesten-3-one is involved in the primary bile acid biosynthesis pathway. 7 alpha,24-Dihydroxy-4-cholesten-3-one is produced from (24S)-Cholest-5-ene-3 beta,7 alpha,24-triol through the action of HSD3B7 (EC:1.1.1.181).

   

Octadecyl cis-p-coumarate

Octadecyl (2E)-3-(4-hydroxyphenyl)prop-2-enoic acid

C27H44O3 (416.329)


Octadecyl cis-p-coumarate is found in potato. Octadecyl cis-p-coumarate is a constituent of Ipomoea batatas (sweet potato). Constituent of Ipomoea batatas (sweet potato). Octadecyl trans-p-coumarate is found in root vegetables and potato.

   

23S,25-dihydroxyvitamin D3

(6R)-6-[(1R,4E,7aR)-4-{2-[(1Z,5R)-5-hydroxy-2-methylidenecyclohexylidene]ethylidene}-7a-methyl-octahydro-1H-inden-1-yl]-2-methylheptane-2,4-diol

C27H44O3 (416.329)


23S,25-dihydroxyvitamin D3 (23S,25-(OH)2D3) is a circulating metabolite of vitamin D3 during vitamin D excess. During hypocalcemia or hypovitaminosis D, 25-OH-D3 is 1alpha-hydroxylated, primarily in kidney, to produce 1,25-(OH)2D3. 1,25-(OH)2D3 is a hormonally active form of vitamin D3 that enhances intestinal calcium transport and promotes mobilization of calcium from bone. In states of vitamin D excess, other pathways of 25-OH-D3 metabolism emerge as alternatives to 1-and 24-hydroxylation. Recently, 25-hydroxyvitamin D3-26,23-lactone (lactone) was identified as a major plasma metabolite in animals receiving large doses of vitamin D. Although the function of the lactone is not known, its 5-fold greater potency of binding to the plasma vitamin D carrier protein, relative to 25-OH-D3, suggests that it may, perhaps indirectly, contribute to vitamin D toxicity. This indicates the existence of an alternate route to lactone formation through a new 25-OH-D3 metabolite, 23,25-(OH)2D3. (PMID: 6286629) [HMDB] 23S,25-dihydroxyvitamin D3 (23S,25-(OH)2D3) is a circulating metabolite of vitamin D3 during vitamin D excess. During hypocalcemia or hypovitaminosis D, 25-OH-D3 is 1alpha-hydroxylated, primarily in kidney, to produce 1,25-(OH)2D3. 1,25-(OH)2D3 is a hormonally active form of vitamin D3 that enhances intestinal calcium transport and promotes mobilization of calcium from bone. In states of vitamin D excess, other pathways of 25-OH-D3 metabolism emerge as alternatives to 1-and 24-hydroxylation. Recently, 25-hydroxyvitamin D3-26,23-lactone (lactone) was identified as a major plasma metabolite in animals receiving large doses of vitamin D. Although the function of the lactone is not known, its 5-fold greater potency of binding to the plasma vitamin D carrier protein, relative to 25-OH-D3, suggests that it may, perhaps indirectly, contribute to vitamin D toxicity. This indicates the existence of an alternate route to lactone formation through a new 25-OH-D3 metabolite, 23,25-(OH)2D3. (PMID: 6286629). D018977 - Micronutrients > D014815 - Vitamins > D004100 - Dihydroxycholecalciferols D018977 - Micronutrients > D014815 - Vitamins > D006887 - Hydroxycholecalciferols

   

Apo-8'-lycopenal

(2E,4E,6Z,8E,10E,12E,14E,16E,18Z)-2,6,11,15,19,23-hexamethyltetracosa-2,4,6,8,10,12,14,16,18,22-decaenal

C30H40O (416.3079)


Apo-8-lycopenal is found in garden tomato. Apo-8-lycopenal is isolated from Lycopersicon esculentum (tomato). Isolated from Lycopersicon esculentum (tomato). Apo-8-lycopenal is found in garden tomato.

   

25,26-dihydroxyvitamin D

(6R)-6-[(1R,3aS,5Z,7aS)-5-{2-[(1Z,5S)-5-hydroxy-2-methylidenecyclohexylidene]ethylidene}-7a-methyl-octahydro-1H-inden-1-yl]-2-methylheptane-1,2-diol

C27H44O3 (416.329)


25,26-(OH)2D3 is a renal microsomal 25-OH-D3 metabolite, whose plasma concentration increases during vitamin D excess concomitantly with an increase in the concentration of lactone. This observation considered with the related structural features of 25,26-(OH)2D3 and lactone (both are oxidized at (C-26) suggested that 25,26(OH)2D3, a metabolite of unknown function, could be a precursor to lactone. In fact, it has been reported that functionalization of C-26 and subsequent lactone formation occurs exclusively in kidney. However, rigorous examination has unambiguously excluded 25S,26-(OH)2D3, the naturally occurring form as a significant lactone precursor. (PMID: 6286629).

   

24R,25-Dihydroxyvitamin D3

(3R,6R)-6-[(1R,3aS,4E,7aR)-4-{2-[(1Z,5S)-5-hydroxy-2-methylidenecyclohexylidene]ethylidene}-7a-methyl-octahydro-1H-inden-1-yl]-2-methylheptane-2,3-diol

C27H44O3 (416.329)


24R,25-Dihydroxyvitamin D3, also known as 24(R),25(OH)2D3, is a vitamin D metabolite; a dihydroxylated form of the seco-steroid. With the identification of a target cell, the growth plate resting zone (RC) chondrocyte, studies indicate that there are specific membrane-associated signal transduction pathways that mediate both rapid, nongenomic, and genomic responses of RC cells to 24(R),25(OH)2D3. These studies indicate that 24(R),25(OH)2D3 plays an important role in endochondral ossification by regulating less mature chondrocytes and promoting their maturation in the endochondral lineage. 24(R),25(OH)2D3 binds RC chondrocyte membranes with high specificity, increasing protein kinase C (PKC) activity. The effect is stereospecific; 24R,25(OH)2D3, but not 24S,25(OH)2D3, causes the increase, indicating a receptor-mediated response. Phospholipase D-2 (PLD2) activity is increased, resulting in increased production of diacylglycerol (DAG), which in turn activates PKC. 24(R),25(OH)2D3 does not cause translocation of PKC to the plasma membrane but activates existing PKCα. There is a rapid decrease in Ca2+ efflux, and the influx is stimulated. 24(R),25(OH)2D3 also reduces arachidonic acid release by decreasing phospholipase A2 (PLA2) activity, thereby decreasing the available substrate for prostaglandin production via the action of cyclooxygenase-1. PGE2 that is produced acts on the EP1 and EP2 receptors expressed by RC cells to downregulate PKC via protein kinase A, but the reduction in PGE2 decreases this negative feedback mechanism. Both pathways converge on MAP kinase, leading to new gene expression. One consequence of this is the production of new matrix vesicles containing PKCα and PKCγ, and an increase in PKC activity. The chondrocytes also produce 24(R),25(OH)2D3, and the secreted metabolite acts directly on the matrix vesicle membrane. Only PKCγ is directly affected by 24(R),25(OH)2D3 in the matrix vesicles, and activity of this isoform is inhibited. This effect may be involved in the control of matrix maturation and turnover. 24(R),25(OH)2D3 causes RC cells to mature along the endochondral developmental pathway, where they become responsive to 1α,25(OH)2D3 and lose responsiveness to 24(R),25(OH)2D3, a characteristic of more mature growth zone (GC) chondrocytes. 1α,25(OH)2D3 elicits its effects on GC through different signal transduction pathways than those used by 24(R),25(OH)2D3 (PMID: 11179745). 24R,25-Dihydroxyvitamin D3 (24(R),25(OH)2D3 ) is a vitamin D metabolite, a dihydroxylated form of the seco-steroid. With the identification of a target cell, the growth plate resting zone (RC) chondrocyte, studies indicate that there are specific membrane-associated signal transduction pathways that mediate both rapid, nongenomic and genomic responses of RC cells to 24(R),25(OH)2D3. These studies indicate that 24(R),25(OH)2D3 plays an important role in endochondral ossification by regulating less mature chondrocytes and promoting their maturation in the endochondral lineage. D018977 - Micronutrients > D014815 - Vitamins > D004100 - Dihydroxycholecalciferols D018977 - Micronutrients > D014815 - Vitamins > D006887 - Hydroxycholecalciferols D000077264 - Calcium-Regulating Hormones and Agents D050071 - Bone Density Conservation Agents

   

Neotigogenin

(1R,2R,2S,4S,5S,7S,8R,9S,12S,13S,16S,18S)-5,7,9,13-tetramethyl-5-oxaspiro[oxane-2,6-pentacyclo[10.8.0.0²,⁹.0⁴,⁸.0¹³,¹⁸]icosane]-16-ol

C27H44O3 (416.329)


Neotigogenin is found in fenugreek. Neotigogenin is a constituent of currant tomato (Lycopersicon pimpinellifolium)

   

(24R)-24,25-Dihydroxycalciol

(3R,6R)-6-[(1R,3aS,4E,7aR)-4-{2-[(1E,5S)-5-hydroxy-2-methylidenecyclohexylidene]ethylidene}-7a-methyl-octahydro-1H-inden-1-yl]-2-methylheptane-2,3-diol

C27H44O3 (416.329)


This compound belongs to the family of Vitamin D and Derivatives. These are compounds containing a secosteroid backbone, usually secoergostane or secocholestane.

   

Secalciferol

(3R)-6-[(4E,7aR)-4-[(2E)-2-[(5S)-5-hydroxy-2-methylidenecyclohexylidene]ethylidene]-7a-methyl-2,3,3a,5,6,7-hexahydro-1H-inden-1-yl]-2-methylheptane-2,3-diol

C27H44O3 (416.329)


This compound belongs to the family of Vitamin D and Derivatives. These are compounds containing a secosteroid backbone, usually secoergostane or secocholestane.

   

(25R)-7alpha,26-dihydroxycholest-4-en-3-one

(1S,2R,9R,10S,11S,14R,15R)-9-hydroxy-14-[(2R,6R)-7-hydroxy-6-methylheptan-2-yl]-2,15-dimethyltetracyclo[8.7.0.0^{2,7}.0^{11,15}]heptadec-6-en-5-one

C27H44O3 (416.329)


(25R)-7alpha,26-dihydroxycholest-4-en-3-one is considered to be practically insoluble (in water) and relatively neutral

   

(25R)-3beta,4beta-dihydroxycholest-5-en-26-al

(2R,6R)-6-[(1S,2R,5S,6R,10S,11S,14R,15R)-5,6-dihydroxy-2,15-dimethyltetracyclo[8.7.0.0^{2,7}.0^{11,15}]heptadec-7-en-14-yl]-2-methylheptanal

C27H44O3 (416.329)


(25R)-3beta,4beta-dihydroxycholest-5-en-26-al is considered to be practically insoluble (in water) and relatively neutral

   

(1R)-5-[2-[(1R,7Ar)-1-[(2R)-6-hydroxy-6-methylheptan-2-yl]-7a-methyl-2,3,3a,5,6,7-hexahydro-1H-inden-4-ylidene]ethylidene]-4-methylidenecyclohexane-1,3-diol

(1R)-5-[2-[(1R,7Ar)-1-[(2R)-6-hydroxy-6-methylheptan-2-yl]-7a-methyl-2,3,3a,5,6,7-hexahydro-1H-inden-4-ylidene]ethylidene]-4-methylidenecyclohexane-1,3-diol

C27H44O3 (416.329)


   

25,26-Dihydroxyvitamin D3

6-{4-[2-(5-hydroxy-2-methylidenecyclohexylidene)ethylidene]-7a-methyl-octahydro-1H-inden-1-yl}-2-methylheptane-1,2-diol

C27H44O3 (416.329)


   

1alpha,24-Dihydroxycholecalciferol

5-{2-[1-(5-hydroxy-6-methylheptan-2-yl)-7a-methyl-hexahydro-1H-inden-4-ylidene]ethylidene}-4-methylidenecyclohexane-1,3-diol

C27H44O3 (416.329)


   

24, 25-Dihydroxy VD3

6-{4-[2-(5-hydroxy-2-methylidenecyclohexylidene)ethylidene]-7a-methyl-octahydro-1H-inden-1-yl}-2-methylheptane-2,3-diol

C27H44O3 (416.329)


   

9-Octadecenoic acid (9Z)-, (2-hydroxy-2-oxido-1,2-oxaphospholan-4-yl)methyl ester

9-Octadecenoic acid (9Z)-, (2-hydroxy-2-oxido-1,2-oxaphospholan-4-yl)methyl ester

C22H41O5P (416.2691)


   

7alpha,12alpha-Dihydroxycholest-4-en-3-one

7,12-Dihydroxy-10,13-dimethyl-17-(6-methylheptan-2-yl)-1,2,6,7,8,9,11,12,14,15,16,17-dodecahydrocyclopenta[a]phenanthren-3-one

C27H44O3 (416.329)


   

19-Nor-1-,25-dihydroxyvitamin D2

5-{2-[1-(6-hydroxy-5,6-dimethylhept-3-en-2-yl)-7a-methyl-octahydro-1H-inden-4-ylidene]ethylidene}cyclohexane-1,3-diol

C27H44O3 (416.329)


   

Apocarotenal

2,6,11,15-tetramethyl-17-(2,6,6-trimethylcyclohex-1-en-1-yl)heptadeca-2,4,6,8,10,12,14,16-octaenal

C30H40O (416.3079)


   

Episarsasapogenin

5,7,9,13-tetramethyl-5-oxaspiro[oxane-2,6-pentacyclo[10.8.0.0^{2,9}.0^{4,8}.0^{13,18}]icosane]-16-ol

C27H44O3 (416.329)


Neotigonenin, also known as sarsasopogenin, is a member of the class of compounds known as triterpenoids. Triterpenoids are terpene molecules containing six isoprene units. Neotigonenin is practically insoluble (in water) and an extremely weak acidic compound (based on its pKa). Neotigonenin can be found in fenugreek, which makes neotigonenin a potential biomarker for the consumption of this food product.

   

Pactimibe

2-{7-[(1-hydroxy-2,2-dimethylpropylidene)amino]-4,6-dimethyl-1-octyl-2,3-dihydro-1H-indol-5-yl}acetate

C25H40N2O3 (416.3039)


D006133 - Growth Substances > D010937 - Plant Growth Regulators > D007210 - Indoleacetic Acids C471 - Enzyme Inhibitor Pactimibe (CS-505 free base) is a dual ACAT1/2 inhibitor with IC50s of 4.9 μM and 3.0 μM, respectively. Pactimibe (CS-505 free base) inhibits ACAT with IC50s of 2.0 μM, 2.7 μM, 4.7 μM in the liver, macrophages and THP-1 cells, respectively[1]. Pactimibe (CS-505 free base) noncompetitively inhibits oleoyl-CoA with a Ki value of 5.6 μM. Moreover, Pactimibe (CS-505 free base) obviously inhibits cholesteryl ester formation with an IC50 of 6.7 μM. Pactimibe (CS-505 free base) possesses anti-atherosclerotic potential with lowering plasma cholesterol activity[2].

   

(1S)-3-[2-[(1R,7Ar)-7a-methyl-1-[(2R)-6-methylheptan-2-yl]-2,3,3a,5,6,7-hexahydro-1H-inden-4-ylidene]ethylidene]-1-hydroperoxy-4-methylidenecyclohexan-1-ol

(1S)-3-[2-[(1R,7Ar)-7a-methyl-1-[(2R)-6-methylheptan-2-yl]-2,3,3a,5,6,7-hexahydro-1H-inden-4-ylidene]ethylidene]-1-hydroperoxy-4-methylidenecyclohexan-1-ol

C27H44O3 (416.329)


   

Homaxisterol D1

Homaxisterol D1

C27H44O3 (416.329)


   
   
   

Viperidone

3beta,9alpha-dihydroxy-5alpha-cholest-7-en-6-one

C27H44O3 (416.329)


   

Dorstenic acid B

(+)-Dorstenic acid B

C27H44O3 (416.329)


   

5alpha,8alpha-Epidioxycholest-6-en-3beta-ol

(-)-5alpha,8alpha-Epidioxycholest-6-en-3beta-ol

C27H44O3 (416.329)


A cholestanoid that is cholest-6-ene substituted by a beta-hydroxy group at position 3 and a peroxy group between positions 5 and 8 (the 5alpha,8alpha stereoisomer). Isolated from the sea urchin Diadema setosum, it exhibits cytotoxicity against variuos cancer cell lines.

   

24beta-Methoxyscalarolide

24beta-Methoxyscalarolide

C26H40O4 (416.2926)


   

12beta,22-Dihydroxy-24-methylscalar-17-en-24,25-olide

12beta,22-Dihydroxy-24-methylscalar-17-en-24,25-olide

C26H40O4 (416.2926)


   

Griffinisterone H

Griffinisterone H

C27H44O3 (416.329)


   

Agaric acid

Agaric acid

C22H40O7 (416.2774)


   

16beta-hydroxy-5alpha-cholest-3,6-dione|16beta-hydroxy-5alpha-cholestane-3,6-dione

16beta-hydroxy-5alpha-cholest-3,6-dione|16beta-hydroxy-5alpha-cholestane-3,6-dione

C27H44O3 (416.329)


   
   

25, 26-Dihydroxy Vitamin D3

25, 26-Dihydroxy Vitamin D3

C27H44O3 (416.329)


   

(3S,3aS,4S,5aS,5bR,7aS,11aS,11bR,13aS,13bS)-octadecahydro-4-hydroxy-3,5b,8,8,11a,13a-hexamethylchryseno[1,2-c]furan-1,13-dione|16beta-hydroxy-24beta-methyl-12-oxoscalarano-25,24-lactone|phyllofolactone L

(3S,3aS,4S,5aS,5bR,7aS,11aS,11bR,13aS,13bS)-octadecahydro-4-hydroxy-3,5b,8,8,11a,13a-hexamethylchryseno[1,2-c]furan-1,13-dione|16beta-hydroxy-24beta-methyl-12-oxoscalarano-25,24-lactone|phyllofolactone L

C26H40O4 (416.2926)


   

16beta-hydroxy-24-methyl-12,24-dioxoscalaran-25-al

16beta-hydroxy-24-methyl-12,24-dioxoscalaran-25-al

C26H40O4 (416.2926)


   

methyl-15alpha-isovaleryloxy-ent-kaurenoate

methyl-15alpha-isovaleryloxy-ent-kaurenoate

C26H40O4 (416.2926)


   

(3S,5E,7E,10S)-3,25-Dihydroxy-9,10-secocholesta-5,7-dien-24-one

(3S,5E,7E,10S)-3,25-Dihydroxy-9,10-secocholesta-5,7-dien-24-one

C27H44O3 (416.329)


   

25,26,27-trisnor-3alpha-hydroxy-lanost-9(11)-en-24-oic acid

25,26,27-trisnor-3alpha-hydroxy-lanost-9(11)-en-24-oic acid

C27H44O3 (416.329)


   

(20S)-20,25-dihydroxy-4-cholecten-3-one|stachsterol

(20S)-20,25-dihydroxy-4-cholecten-3-one|stachsterol

C27H44O3 (416.329)


   

glaciasterol A

glaciasterol A

C26H40O4 (416.2926)


   

(20S)-20-hydroxycholestane-3,16-dione

(20S)-20-hydroxycholestane-3,16-dione

C27H44O3 (416.329)


   

(20R,22R)-20,22-dihydroxycholest-4-en-3-one|20R,22R-dihydroxycholest-4-en-3-one

(20R,22R)-20,22-dihydroxycholest-4-en-3-one|20R,22R-dihydroxycholest-4-en-3-one

C27H44O3 (416.329)


   

Calicoferol B

Calicoferol B

C27H44O3 (416.329)


   

norscalaral A|norscalaral B

norscalaral A|norscalaral B

C26H40O4 (416.2926)


   

5,7-dihydroxy-2-heptadecyl-chromone

5,7-dihydroxy-2-heptadecyl-chromone

C26H40O4 (416.2926)


   

6-Angeloyloxy-kolavensaeure-methylester|6-Angeloyloxykolavensaeure-methylester

6-Angeloyloxy-kolavensaeure-methylester|6-Angeloyloxykolavensaeure-methylester

C26H40O4 (416.2926)


   

(3beta, 7beta, 22E)-Cholesta-5, 22-diene-3, 7, 19-triol

(3beta, 7beta, 22E)-Cholesta-5, 22-diene-3, 7, 19-triol

C27H44O3 (416.329)


   

(3S,5Z,7E,25R)-9,10-Secocholesta-5,7,10(19)-triene-3,25,26-triol

(3S,5Z,7E,25R)-9,10-Secocholesta-5,7,10(19)-triene-3,25,26-triol

C27H44O3 (416.329)


   

3,26-Dihydroxycholest-5-en-22-one #

3,26-Dihydroxycholest-5-en-22-one #

C27H44O3 (416.329)


   

cabraleahydroxylactone

cabraleahydroxylactone

C27H44O3 (416.329)


A tetracyclic triterpenoid isolated from the stems of Aglaia abbreviata.

   

cholesta-8(14),24-dien-3beta,5alpha,6alpha-triol

cholesta-8(14),24-dien-3beta,5alpha,6alpha-triol

C27H44O3 (416.329)


   

(Z)-p-coumaryl stearate

(Z)-p-coumaryl stearate

C27H44O3 (416.329)


   

(16beta,20xi)-16,20-Dihydroxycholest-4-en-3-one

(16beta,20xi)-16,20-Dihydroxycholest-4-en-3-one

C27H44O3 (416.329)


   
   

plakortolide L

plakortolide L

C26H40O4 (416.2926)


An organic heterobicyclic compound that is a cyclic peroxy compound isolated from the Australian marine sponge Plakinastrella clathrata.

   

24,25-Dihydro-3,6-Dihydroxycholesta-9(11),24-dien-23-one|3beta,6alpha-Dihydroxy-5alpha-cholest-9(11)-en-23-on

24,25-Dihydro-3,6-Dihydroxycholesta-9(11),24-dien-23-one|3beta,6alpha-Dihydroxy-5alpha-cholest-9(11)-en-23-on

C27H44O3 (416.329)


   

2-hydroxy-1,2,3-nonadecanetricarboxylic acid

2-hydroxy-1,2,3-nonadecanetricarboxylic acid

C22H40O7 (416.2774)


   

3-(Acetyloxy)chol-5-en-24-oic acid

3-(Acetyloxy)chol-5-en-24-oic acid

C26H40O4 (416.2926)


   

(23S)-17alpha,23-epoxy-3beta,24xi-dihydroxy-27,28,29-trisnorlanost-8-ene

(23S)-17alpha,23-epoxy-3beta,24xi-dihydroxy-27,28,29-trisnorlanost-8-ene

C27H44O3 (416.329)


   

cholesta-8,24-dien-3beta,5alpha,6alpha-triol

cholesta-8,24-dien-3beta,5alpha,6alpha-triol

C27H44O3 (416.329)


   

25-Hydroperoxycholesta-5, 23-dien-3beta-ol

25-Hydroperoxycholesta-5, 23-dien-3beta-ol

C27H44O3 (416.329)


   

N-(16-amino-4,8,13-triazahexadecyl)-1H-indole-3-acetamide

N-(16-amino-4,8,13-triazahexadecyl)-1H-indole-3-acetamide

C23H40N6O (416.3263)


   

3,29-Dihydroxy-24,25,26,27-tetranorlanost-8-eno-23,17-lactone

3,29-Dihydroxy-24,25,26,27-tetranorlanost-8-eno-23,17-lactone

C26H40O4 (416.2926)


   

Cyclomicrophyllin-B

Cyclomicrophyllin-B

C26H44N2O2 (416.3403)


   

N-(16-amino-5,9,13-triazahexadecyl)-1H-indole-3-acetamide

N-(16-amino-5,9,13-triazahexadecyl)-1H-indole-3-acetamide

C23H40N6O (416.3263)


   

3-keto-22-epi-28-nor-cathasterone

3-keto-22-epi-28-nor-cathasterone

C27H44O3 (416.329)


   

2-O-[(3R)-3-(acetyloxy)octadecanoyl]glycerol

2-O-[(3R)-3-(acetyloxy)octadecanoyl]glycerol

C23H44O6 (416.3138)


   

Melithasterol A

Melithasterol A

C27H44O3 (416.329)


   

AGN-PC-0JRXGP

AGN-PC-0JRXGP

C29H36O2 (416.2715)


   

3beta-hydroxy-4,4,14-trimethyl-9beta,19-cyclo-5alpha-cholan-24-oic acid|3beta-Hydroxy-4,4,14-trimethyl-9beta,19-cyclo-5alpha-cholan-24-saeure|3beta-Hydroxy-9,19-cyclo-25,26,27-trisnor-lanost-24-carbonsaeure|3beta-hydroxy-9,19-cycloart-24-oic acid|3beta-Hydroxy-9beta,19-cyclo-25,26,27-trinor-lanostan-24-saeure

3beta-hydroxy-4,4,14-trimethyl-9beta,19-cyclo-5alpha-cholan-24-oic acid|3beta-Hydroxy-4,4,14-trimethyl-9beta,19-cyclo-5alpha-cholan-24-saeure|3beta-Hydroxy-9,19-cyclo-25,26,27-trisnor-lanost-24-carbonsaeure|3beta-hydroxy-9,19-cycloart-24-oic acid|3beta-Hydroxy-9beta,19-cyclo-25,26,27-trinor-lanostan-24-saeure

C27H44O3 (416.329)


   

astrogorgol K

astrogorgol K

C27H44O3 (416.329)


   

(1R,2S,4R,6S)-4-[(S)-1-hydroxydodecyl]-6-isopropyl-3-methyl-5H-spiro{bicyclo[2.2.2]oct-[2]-ene-7,2-furan}-5-one|yaoshanenolide B

(1R,2S,4R,6S)-4-[(S)-1-hydroxydodecyl]-6-isopropyl-3-methyl-5H-spiro{bicyclo[2.2.2]oct-[2]-ene-7,2-furan}-5-one|yaoshanenolide B

C27H44O3 (416.329)


   

6beta,16beta-dihydroxycholest-4-en-3-one

6beta,16beta-dihydroxycholest-4-en-3-one

C27H44O3 (416.329)


   

3beta,12beta-dihydroxy-25,26,27-trinordammara-22-en-24,20-olide

3beta,12beta-dihydroxy-25,26,27-trinordammara-22-en-24,20-olide

C26H40O4 (416.2926)


   

(22E)-3beta,5alpha-dihydroxycholest-22-en-6-one

(22E)-3beta,5alpha-dihydroxycholest-22-en-6-one

C27H44O3 (416.329)


   

3beta,6alpha-dihydroxycholest-8-en-23-one|grandol A

3beta,6alpha-dihydroxycholest-8-en-23-one|grandol A

C27H44O3 (416.329)


   

12alpha,22-dihydroxy-24-methyl-24-oxoscalar-16-en-25alpha-al

12alpha,22-dihydroxy-24-methyl-24-oxoscalar-16-en-25alpha-al

C26H40O4 (416.2926)


   

12beta-hydrocimilactone

12beta-hydrocimilactone

C26H40O4 (416.2926)


   

(4R,5S,8S,9S,10S,13S,14R,17S)-22,29,30-trinor-shion-3-one-21-acid|astershionone C

(4R,5S,8S,9S,10S,13S,14R,17S)-22,29,30-trinor-shion-3-one-21-acid|astershionone C

C27H44O3 (416.329)


   

7-oxo-5-cholesten-3beta,19-diol

7-oxo-5-cholesten-3beta,19-diol

C27H44O3 (416.329)


   

lansilactone

lansilactone

C27H44O3 (416.329)


   

(22E)-cholesta-7,22-diene-3beta,5alpha,6beta,9alpha-tetrol

(22E)-cholesta-7,22-diene-3beta,5alpha,6beta,9alpha-tetrol

C27H44O3 (416.329)


   

(22R,25)-epoxycholest-7-ene-3beta,4beta-diol

(22R,25)-epoxycholest-7-ene-3beta,4beta-diol

C27H44O3 (416.329)


   

12-O-deacetyl-12-epi-19-O-methylscalarin

12-O-deacetyl-12-epi-19-O-methylscalarin

C26H40O4 (416.2926)


   

17alpha-hydroxy-22,23-epoxycholest-5-en-3beta-ol

17alpha-hydroxy-22,23-epoxycholest-5-en-3beta-ol

C27H44O3 (416.329)


   

N-(16-amino-4,8,12-triazahexadecyl)-1H-indole-3-acetamide

N-(16-amino-4,8,12-triazahexadecyl)-1H-indole-3-acetamide

C23H40N6O (416.3263)


   

cholesta-5,24-diene-1alpha,3beta,11alpha-triol

cholesta-5,24-diene-1alpha,3beta,11alpha-triol

C27H44O3 (416.329)


   

Guggulsterol IV

Guggulsterol IV

C27H44O3 (416.329)


   

5-n-(2-oxo-14-(Z)-heneicosenyl)resorcinol

5-n-(2-oxo-14-(Z)-heneicosenyl)resorcinol

C27H44O3 (416.329)


   

SCHEMBL20530444

SCHEMBL20530444

C26H40O4 (416.2926)


   

spirost-5-ene-3beta,12beta-diol

spirost-5-ene-3beta,12beta-diol

C26H40O4 (416.2926)


   

3beta,5alpha-Dihydroxy-cholest-7-en-6-on|3beta,5alpha-dihydroxycholest-7-en-6-one|3beta,5alpha-dihydroxycholesta-7-en-6-one|3beta-5alpha-dihydroxycholest-7-en-6-one|cholest-7-ene-3beta,5alpha-diol-6-one|DHCEO

3beta,5alpha-Dihydroxy-cholest-7-en-6-on|3beta,5alpha-dihydroxycholest-7-en-6-one|3beta,5alpha-dihydroxycholesta-7-en-6-one|3beta-5alpha-dihydroxycholest-7-en-6-one|cholest-7-ene-3beta,5alpha-diol-6-one|DHCEO

C27H44O3 (416.329)


   

curvicollide C

curvicollide C

C26H40O4 (416.2926)


   

1beta,3alpha-dihydroxy-furost-5-ene

1beta,3alpha-dihydroxy-furost-5-ene

C27H44O3 (416.329)


   

methyl-12alpha-isovaleroyloxy-ent-kaur-16-en-19-oate

methyl-12alpha-isovaleroyloxy-ent-kaur-16-en-19-oate

C26H40O4 (416.2926)


   

(3S,4R,22R)-cholest-7,24-diene-3,4,22-triol

(3S,4R,22R)-cholest-7,24-diene-3,4,22-triol

C27H44O3 (416.329)


   

plakortone N

plakortone N

C26H40O4 (416.2926)


An organic heterobicyclic compound consisting of a gamma-lactone ring fused onto a substituted tetrahydrofuran ring. It is isolated from the Australian marine sponge Plakinastrella clathrata.

   

Oleoyl 3-carbacyclic Phosphatidic Acid

Oleoyl 3-carbacyclic Phosphatidic Acid

C22H41O5P (416.2691)


   

Maydispenoid A

Maydispenoid A

C26H40O4 (416.2926)


   

Agaric_acid

1-hexadecyl-2-hydroxypropane-1,2,3-tricarboxylic acid

C22H40O7 (416.2774)


Agaric acid is a natural product found in Ischnoderma benzoinum with data available. C471 - Enzyme Inhibitor Agaric acid (Agaricinic Acid) is obtained from various plants of the fungous tribe, i.e. Polyporus officinalis and Polyporus igniarius. Agaric acid induces mitochondrial permeability transition through its interaction with the adenine nucleotide translocase. Agaric acid promotes efflux of accumulated Ca2+, collapse of transmembrane potential, and mitochondrial swelling. Agaric acid is used to regulate lipid metabolism[1]. Agaric acid (Agaricinic Acid) is obtained from various plants of the fungous tribe, i.e. Polyporus officinalis and Polyporus igniarius. Agaric acid induces mitochondrial permeability transition through its interaction with the adenine nucleotide translocase. Agaric acid promotes efflux of accumulated Ca2+, collapse of transmembrane potential, and mitochondrial swelling. Agaric acid is used to regulate lipid metabolism[1]. Agaric acid (Agaricinic Acid) is obtained from various plants of the fungous tribe, i.e. Polyporus officinalis and Polyporus igniarius. Agaric acid induces mitochondrial permeability transition through its interaction with the adenine nucleotide translocase. Agaric acid promotes efflux of accumulated Ca2+, collapse of transmembrane potential, and mitochondrial swelling. Agaric acid is used to regulate lipid metabolism[1].

   

smilagenin

Isosarsasapogenin

C27H44O3 (416.329)


Origin: Plant; Formula(Parent): C27H44O3; Bottle Name:Smilagenin; PRIME Parent Name:Smilagenin; PRIME in-house No.:S0345; SubCategory_DNP: The sterols, Cholestanes Smilagenin (SMI) is a small-molecule steroidal sapogenin from Anemarrhena asphodeloides and Pelargonium hortorum widely used in traditional Chinese medicine for treating chronic neurodegeneration diseases[1]. Smilagenin (SMI) improves memory of aged rats by increasing the muscarinic receptor subtype 1 (M1)-receptor density[2]. Smilagenin (SMI) attenuates Aβ(25-35)-induced neurodegenerationvia stimulating the gene expression of brain-derived neurotrophic factor, may represents a novel therapeutic strategy for AD[3]. Smilagenin (SMI) is a small-molecule steroidal sapogenin from Anemarrhena asphodeloides and Pelargonium hortorum widely used in traditional Chinese medicine for treating chronic neurodegeneration diseases[1]. Smilagenin (SMI) improves memory of aged rats by increasing the muscarinic receptor subtype 1 (M1)-receptor density[2]. Smilagenin (SMI) attenuates Aβ(25-35)-induced neurodegenerationvia stimulating the gene expression of brain-derived neurotrophic factor, may represents a novel therapeutic strategy for AD[3]. Smilagenin (SMI) is a small-molecule steroidal sapogenin from Anemarrhena asphodeloides and Pelargonium hortorum widely used in traditional Chinese medicine for treating chronic neurodegeneration diseases[1]. Smilagenin (SMI) improves memory of aged rats by increasing the muscarinic receptor subtype 1 (M1)-receptor density[2]. Smilagenin (SMI) attenuates Aβ(25-35)-induced neurodegenerationvia stimulating the gene expression of brain-derived neurotrophic factor, may represents a novel therapeutic strategy for AD[3].

   

Neotigogenin

(25S)-5alpha-spirostan-3beta-ol

C27H44O3 (416.329)


Origin: Plant; SubCategory_DNP: The sterols, Cholestanes

   

Tigogenin_major

Tigogenin_major

C27H44O3 (416.329)


   

Agaric Acid_major

Agaric Acid_major

C22H40O7 (416.2774)


   

Agaric Acid_86.8\\%

Agaric Acid_86.8\\%

C22H40O7 (416.2774)


   

Tigogenin_minor

Tigogenin_minor

C27H44O3 (416.329)


   

7-OOH-5,8-dien-3beta-ol

7alpha-hydroperoxy-cholesta-5,8-dien-3beta-ol

C27H44O3 (416.329)


   

EnP(5,8)

5alpha,8alpha-epidioxy-cholest-6-en-3beta-ol

C27H44O3 (416.329)


   

4-cholesten-7alpha,24S-diol-3-one

7alpha,24S-dihydroxycholest-4-en-3-one

C27H44O3 (416.329)


   

Ala Ala Lys Lys

(2S)-6-amino-2-[(2S)-6-amino-2-[(2S)-2-[(2S)-2-aminopropanamido]propanamido]hexanamido]hexanoic acid

C18H36N6O5 (416.2747)


   

Ala Lys Ala Lys

(2S)-6-amino-2-[(2S)-2-[(2S)-6-amino-2-[(2S)-2-aminopropanamido]hexanamido]propanamido]hexanoic acid

C18H36N6O5 (416.2747)


   

Ala Lys Lys Ala

(2S)-2-[(2S)-6-amino-2-[(2S)-6-amino-2-[(2S)-2-aminopropanamido]hexanamido]hexanamido]propanoic acid

C18H36N6O5 (416.2747)


   

Lys Ala Ala Lys

(2S)-6-amino-2-[(2S)-2-[(2S)-2-[(2S)-2,6-diaminohexanamido]propanamido]propanamido]hexanoic acid

C18H36N6O5 (416.2747)


   

Lys Ala Lys Ala

(2S)-2-[(2S)-6-amino-2-[(2S)-2-[(2S)-2,6-diaminohexanamido]propanamido]hexanamido]propanoic acid

C18H36N6O5 (416.2747)


   

Lys Lys Ala Ala

(2S)-2-[(2S)-2-[(2S)-6-amino-2-[(2S)-2,6-diaminohexanamido]hexanamido]propanamido]propanoic acid

C18H36N6O5 (416.2747)


   

25,26-hydroxyvitamin D3

25,26-hydroxyvitamin D3

C27H44O3 (416.329)


   

Dormatinone

(25S)-3beta,26-dihydroxycholest-5-en-22-one

C27H44O3 (416.329)


   

(5Z,7E)-(1S,3R,24R,25S)-25,26-epoxy-27-nor-9,10-seco-5,7,10(19)-cholestatriene-1,3,24-triol

(24R,25S)-25,26-epoxy-1α,24-dihydroxy-27-norvitamin D3 / (24R,25S)-25,26-epoxy-1α,24-dihydroxy-27-norcholecalciferol

C26H40O4 (416.2926)


   

(5Z,7E)-(1S,3R,24S,25R)-25,26-epoxy-27-nor-9,10-seco-5,7,10(19)-cholestatriene-1,3,24-triol

(24S,25R)-25,26-epoxy-1α,24-dihydroxy-27-norvitamin D3 / (24S,25R)-25,26-epoxy-1α,24-dihydroxy-27-norcholecalciferol

C26H40O4 (416.2926)


   

(7E)-(3S,6R)-6,19-epidioxy-9,10-seco-5(10),7-cholestadien-3-ol

(6R)-6,19-epidioxy-6,19-dihydrovitamin D3 / (6R)-6,19-epidioxy-6,19-dihydrocholecalciferol

C27H44O3 (416.329)


   

(7E)-(3S,6S)-6,19-epidioxy-9,10-seco-5(10),7-cholestadien-3-ol

(6S)-6,19-epidioxy-6,19-dihydrovitamin D3 / (6S)-6,19-epidioxy-6,19-dihydrocholecalciferol

C27H44O3 (416.329)


   

1α,18-dihydroxyvitamin D3 / 1α,18-dihydroxycholecalciferol

1α,18-dihydroxyvitamin D3 / 1α,18-dihydroxycholecalciferol

C27H44O3 (416.329)


   

(24S)-1α,24-dihydroxyvitamin D3 / (24S)-1α,24-dihydroxycholecalciferol

(24S)-1α,24-dihydroxyvitamin D3 / (24S)-1α,24-dihydroxycholecalciferol

C27H44O3 (416.329)


   

1α,25-dihydroxy-3-epivitamin D3 / 1α,25-dihydroxy-3-epicholecalciferol

1α,25-dihydroxy-3-epivitamin D3 / 1α,25-dihydroxy-3-epicholecalciferol

C27H44O3 (416.329)


   

1α,25-dihydroxy-14-epivitamin D3 / 1α,25-dihydroxy-14-epicholecalciferol

1α,25-dihydroxy-14-epivitamin D3 / 1α,25-dihydroxy-14-epicholecalciferol

C27H44O3 (416.329)


   

1α,25-dihydroxy-14-epiprevitamin D3 / 1α,25-dihydroxy-14-epiprecholecalciferol

1α,25-dihydroxy-14-epiprevitamin D3 / 1α,25-dihydroxy-14-epiprecholecalciferol

C27H44O3 (416.329)


   

1α,25-dihydroxy-20-epivitamin D3 / 1α,25-dihydroxy-20-epicholecalciferol

1α,25-dihydroxy-20-epivitamin D3 / 1α,25-dihydroxy-20-epicholecalciferol

C27H44O3 (416.329)


   

(5E)-1α,25-dihydroxyvitamin D3 / (5E)-1α,25-dihydroxycholecalciferol

(5E)-1α,25-dihydroxyvitamin D3 / (5E)-1α,25-dihydroxycholecalciferol

C27H44O3 (416.329)


   

1β,25-dihydroxyvitamin D3 / 1β,25-dihydroxycholecalciferol

1β,25-dihydroxyvitamin D3 / 1β,25-dihydroxycholecalciferol

C27H44O3 (416.329)


   

1β,25-dihydroxy-3-epivitamin D3 / 1β,25-dihydroxy-3-epicholecalciferol

1β,25-dihydroxy-3-epivitamin D3 / 1β,25-dihydroxy-3-epicholecalciferol

C27H44O3 (416.329)


   

18,25-dihydroxyvitamin D3 / 18,25-dihydroxycholecalciferol

(5Z,7E)-(3S)-9,10-seco-5,7,10(19)-cholestatriene-3,18,25-triol

C27H44O3 (416.329)


   

(22R)-22,25-dihydroxyvitamin D3 / (22R)-22,25-dihydroxycholecalciferol

(22R)-22,25-dihydroxyvitamin D3 / (22R)-22,25-dihydroxycholecalciferol

C27H44O3 (416.329)


   

(22S)-22,25-dihydroxyvitamin D3 / (22S)-22,25-dihydroxycholecalciferol

(22S)-22,25-dihydroxyvitamin D3 / (22S)-22,25-dihydroxycholecalciferol

C27H44O3 (416.329)


   

(23R)-23,25-dihydroxyvitamin D3 / (23R)-23,25-dihydroxycholecalciferol

(23R)-23,25-dihydroxyvitamin D3 / (23R)-23,25-dihydroxycholecalciferol

C27H44O3 (416.329)


   

(23S)-23,25-dihydroxyvitamin D3 / (23S)-23,25-dihydroxycholecalciferol

(23S)-23,25-dihydroxyvitamin D3 / (23S)-23,25-dihydroxycholecalciferol

C27H44O3 (416.329)


   

(24R)-24,25-dihydroxyvitamin D3 / (24R)-24,25-dihydroxycholecalciferol

(24R)-24,25-dihydroxyvitamin D3 / (24R)-24,25-dihydroxycholecalciferol

C27H44O3 (416.329)


   

(24S)-24,25-dihydroxyvitamin D3 / (24S)-24,25-dihydroxycholecalciferol

(24S)-24,25-dihydroxyvitamin D3 / (24S)-24,25-dihydroxycholecalciferol

C27H44O3 (416.329)


   

(25R)-25,26-dihydroxyvitamin D3 / (25R)-25,26-dihydroxycholecalciferol

(25R)-25,26-dihydroxyvitamin D3 / (25R)-25,26-dihydroxycholecalciferol

C27H44O3 (416.329)


   

(25S)-25,26-dihydroxyvitamin D3 / (25S)-25,26-dihydroxycholecalciferol

(25S)-25,26-dihydroxyvitamin D3 / (25S)-25,26-dihydroxycholecalciferol

C27H44O3 (416.329)


   

(7E)-(1R,3R)-2-methylene-19-nor-9,10-seco-5,7-cholestadiene-1,3,25-triol

1α,25-dihydroxy-2-methylene-19-norvitamin D3 / 1α,25-dihydroxy-2-methylene-19-norcholecalciferol

C27H44O3 (416.329)


   

(7E)-(1R,3R,20S)-2-methylene-19-nor-9,10-seco-5,7-cholestadiene-1,3,25-triol

1α,25-dihydroxy-2-methylene-19-nor-20-epivitamin D3 / 1α,25-dihydroxy-2-methylene-19-nor-20-epicholecalciferol

C27H44O3 (416.329)


   

1α,25-Dihydroxy-16-ene-19-nor-24-oxovitamin D3

(5Z,7E,16Z)-(1R,3R)-19-nor-24-oxo-9,10-seco-5,7,16-cholestatrien-1,3,25-triol

C26H40O4 (416.2926)


   

1α,25-Dihydroxy-previtamin D3

(4E,6Z,8Z)-(1S,3R)-4-methyl-9,10-seco-5,7,10(19)-cholestatriene-1,3,25-triol

C27H44O3 (416.329)


   

3α-Hydroxy-5β-cholest-24-en-26-oic acid

3α-Hydroxy-5β-cholest-24-en-26-oic acid

C27H44O3 (416.329)


   

7α,27-dihydroxycholestenone

7alpha,26-dihydroxycholest-4-en-3-one

C27H44O3 (416.329)


   

3beta,23S,25-dihydroxyvitamin D3

3beta,23S,25-dihydroxyvitamin D3

C27H44O3 (416.329)


   

Cholestenoic acid

3beta-Hydroxycholest-5-en-25R-26-oic acid

C27H44O3 (416.329)


   

Osteo D

24(R),25-Dihydroxycholecalciferol

C27H44O3 (416.329)


   

23,25-Dihydroxyvitamin D3

(3beta,5Z,7E)-9,10-Secocholesta-5,7,10(19)-triene-3,23,25-triol

C27H44O3 (416.329)


   

6α-Testosterone Enanthate

(6S)-6-hydroxy-10,13-dimethyl-3-oxo-2,3,6,7,8,9,10,11,12,13,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-17-yl heptanoate

C26H40O4 (416.2926)


   

6β-Testosterone Enanthate

(6R,10R,13S,17S)-6-hydroxy-10,13-dimethyl-3-oxo-2,3,6,7,8,9,10,11,12,13,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-17-yl heptanoate

C26H40O4 (416.2926)


   

7alpha,12alpha-Dihydroxycholest-4-en-3-one

7alpha,12alpha-Dihydroxycholest-4-en-3-one

C27H44O3 (416.329)


   

3alpha-Hydroxy-5beta-cholest-24-en-26-oic acid

3alpha-Hydroxy-5beta-cholest-24-en-26-oic acid

C27H44O3 (416.329)


   

3beta,27-dihydroxy-5-cholesten-7-one

(25R)-7-oxo-cholest-5-en-3beta,27-diol

C27H44O3 (416.329)


   

Octadecyl e-P-coumarate

octadecyl (2E)-3-(4-hydroxyphenyl)prop-2-enoate

C27H44O3 (416.329)


   

apo-3-Lycopenal

(2E,4E,6Z,8E,10E,12E,14E,16E,18Z)-2,6,11,15,19,23-hexamethyltetracosa-2,4,6,8,10,12,14,16,18,22-decaenal

C30H40O (416.3079)


   

ascr#30

16R-(3R,5R-dihydroxy-6S-methyl-(2H)-tetrahydropyran-2-yloxy)-heptadecanoic acid

C23H44O6 (416.3138)


An (omega-1)-hydroxy fatty acid ascaroside obtained by formal condensation of the alcoholic hydroxy group of (16R)-16-hydroxymargaric acid with ascarylopyranose (the alpha anomer). It is a metabolite of the nematode Caenorhabditis elegans.

   

oscr#30

17-(3R,5R-dihydroxy-6S-methyl-(2H)-tetrahydropyran-2-yloxy)-heptadecanoic acid

C23H44O6 (416.3138)


An omega-hydroxy fatty acid ascaroside obtained by formal condensation of the alcoholic hydroxy group of 17-hydroxyheptadecanoic acid with ascarylopyranose (the alpha anomer). It is a metabolite of the nematode Caenorhabditis elegans.

   

DHCEO

3beta,5alpha-dihydroxycholest-7-en-6-one

C27H44O3 (416.329)


   

Pharaonoid B

11beta-hydroxy-19-Nor-1,10:9,10-disecoergosta-3-ene-6-1-oxa-1-one

C27H44O3 (416.329)


   

(24R,25S)-25,26-epoxy-1alpha,24-dihydroxy-27-norvitamin D3

(5Z,7E)-(1S,3R,24R,25S)-25,26-epoxy-27-nor-9,10-seco-5,7,10(19)-cholestatriene-1,3,24-triol

C26H40O4 (416.2926)


   

(24S,25R)-25,26-epoxy-1alpha,24-dihydroxy-27-norvitamin D3

(5Z,7E)-(1S,3R,24S,25R)-25,26-epoxy-27-nor-9,10-seco-5,7,10(19)-cholestatriene-1,3,24-triol

C26H40O4 (416.2926)


   

(6R)-6,19-epidioxy-6,19-dihydrovitamin D3

(7E)-(3S,6R)-6,19-epidioxy-9,10-seco-5(10),7-cholestadien-3-ol

C27H44O3 (416.329)


   

(6S)-6,19-epidioxy-6,19-dihydrovitamin D3

(7E)-(3S,6S)-6,19-epidioxy-9,10-seco-5(10),7-cholestadien-3-ol

C27H44O3 (416.329)


   

(7E)-(3S,6R)-6-hydroperoxy-9,10-seco-4,7,10(19)-cholestatrien-3-ol

(7E)-(3S,6R)-6-hydroperoxy-9,10-seco-4,7,10(19)-cholestatrien-3-ol

C27H44O3 (416.329)


   

(7E)-(3S,6S)-6-hydroperoxy-9,10-seco-4,7,10(19)-cholestatrien-3-ol

(7E)-(3S,6S)-6-hydroperoxy-9,10-seco-4,7,10(19)-cholestatrien-3-ol

C27H44O3 (416.329)


   

1alpha,18-dihydroxyvitamin D3 / 1alpha,18-dihydroxycholecalciferol

1alpha,18-dihydroxyvitamin D3 / 1alpha,18-dihydroxycholecalciferol

C27H44O3 (416.329)


   

(24R)-1alpha,24-dihydroxyvitamin D3

(5Z,7E)-(1S,3R,24R)-9,10-seco-5,7,10(19)-cholestatriene-1,3,24-triol

C27H44O3 (416.329)


   

1alpha,25-dihydroxyvitamin D3 / 1alpha,25-dihydroxycholecalciferol / calcitriol

1alpha,25-dihydroxyvitamin D3 / 1alpha,25-dihydroxycholecalciferol / calcitriol

C27H44O3 (416.329)


   

1alpha,25-dihydroxy-3-epivitamin D3 / 1alpha,25-dihydroxy-3-epicholecalciferol

1alpha,25-dihydroxy-3-epivitamin D3 / 1alpha,25-dihydroxy-3-epicholecalciferol

C27H44O3 (416.329)


   

1alpha,25-dihydroxy-14-epivitamin D3 / 1alpha,25-dihydroxy-14-epicholecalciferol

1alpha,25-dihydroxy-14-epivitamin D3 / 1alpha,25-dihydroxy-14-epicholecalciferol

C27H44O3 (416.329)


   

1alpha,25-dihydroxy-14-epiprevitamin D3 / 1alpha,25-dihydroxy-14-epiprecholecalciferol

1alpha,25-dihydroxy-14-epiprevitamin D3 / 1alpha,25-dihydroxy-14-epiprecholecalciferol

C27H44O3 (416.329)


   

1alpha,25-dihydroxy-20-epivitamin D3 / 1alpha,25-dihydroxy-20-epicholecalciferol

1alpha,25-dihydroxy-20-epivitamin D3 / 1alpha,25-dihydroxy-20-epicholecalciferol

C27H44O3 (416.329)


   

(5E)-1alpha,25-dihydroxyvitamin D3 / (5E)-1alpha,25-dihydroxycholecalciferol

(5E)-1alpha,25-dihydroxyvitamin D3 / (5E)-1alpha,25-dihydroxycholecalciferol

C27H44O3 (416.329)


   

1beta,25-dihydroxyvitamin D3 / 1beta,25-dihydroxycholecalciferol

(5Z,7E)-(1R,3R)-9,10-seco-5,7,10(19)-cholestatriene-1,3,25-triol

C27H44O3 (416.329)


   

1beta,25-dihydroxy-3-epivitamin D3 / 1beta,25-dihydroxy-3-epicholecalciferol

1beta,25-dihydroxy-3-epivitamin D3 / 1beta,25-dihydroxy-3-epicholecalciferol

C27H44O3 (416.329)


   

1alpha,25-dihydroxy-2-methylene-19-norvitamin D3

(7E)-(1R,3R)-2-methylene-19-nor-9,10-seco-5,7-cholestadiene-1,3,25-triol

C27H44O3 (416.329)


   

1alpha,25-dihydroxy-2-methylene-19-nor-20-epivitamin D3

(7E)-(1R,3R,20S)-2-methylene-19-nor-9,10-seco-5,7-cholestadiene-1,3,25-triol

C27H44O3 (416.329)


   

1alpha,25-Dihydroxy-16-ene-19-nor-24-oxovitamin D3

(5Z,7E,16Z)-(1R,3R)-19-nor-24-oxo-9,10-seco-5,7,16-cholestatrien-1,3,25-triol

C26H40O4 (416.2926)


   

1alpha,25-Dihydroxy-previtamin D3

(4E,6Z,8Z)-(1S,3R)-4-methyl-9,10-seco-5,7,10(19)-cholestatriene-1,3,25-triol

C27H44O3 (416.329)


D018977 - Micronutrients > D014815 - Vitamins > D004100 - Dihydroxycholecalciferols D018977 - Micronutrients > D014815 - Vitamins > D006887 - Hydroxycholecalciferols

   

Subergorgiaol A

9,10-seco-1,3,5(10)-cholestatrien-3,8beta,9alpha-triol

C27H44O3 (416.329)


   

Paricalcitol

(1R,3R,7E)-17beta-[(2R,3E,5S)-6-hydroxy-5,6-dimethylhept-3-en-2-yl]-9,10-secoestra-5,7-diene-1,3-diol

C27H44O3 (416.329)


H - Systemic hormonal preparations, excl. sex hormones and insulins > H05 - Calcium homeostasis > H05B - Anti-parathyroid agents D018977 - Micronutrients > D014815 - Vitamins > D004872 - Ergocalciferols

   

dafa#3

(+)-3a-hydroxy-(5a,25S)-3-oxocholest-7-en-26-oic acid

C27H44O3 (416.329)


   

dafa#6

(+)-3a-hydroxy-(5b,25S)-3-oxocholest-7-en-26-oic acid

C27H44O3 (416.329)


   

butyl prop-2-enoate,2-ethylhexyl prop-2-enoate,styrene

butyl prop-2-enoate,2-ethylhexyl prop-2-enoate,styrene

C26H40O4 (416.2926)


   

4-N-OCTADECYLOXYCINNAMIC ACID

4-N-OCTADECYLOXYCINNAMIC ACID

C27H44O3 (416.329)


   

(R)-3-Aminotetrahydrofuran hydrochloride

(R)-3-Aminotetrahydrofuran hydrochloride

C28H36N2O (416.2827)


   

(1R,5Z)-5-[(2E)-2-[(1R,3aS,7aR)-1-[(2R)-6-hydroxy-6-methylheptan-2-yl]-7a-methyl-2,3,3a,5,6,7-hexahydro-1H-inden-4-ylidene]ethylidene]-4-methylidenecyclohexane-1,3-diol

(1R,5Z)-5-[(2E)-2-[(1R,3aS,7aR)-1-[(2R)-6-hydroxy-6-methylheptan-2-yl]-7a-methyl-2,3,3a,5,6,7-hexahydro-1H-inden-4-ylidene]ethylidene]-4-methylidenecyclohexane-1,3-diol

C27H44O3 (416.329)


   

1-epi-Calcitriol

1-epi-Calcitriol

C27H44O3 (416.329)


   

Calcitriol

(5Z)-5-[(2E)-2-[1-(6-hydroxy-6-methylheptan-2-yl)-7a-methyl-2,3,3a,5,6,7-hexahydro-1H-inden-4-ylidene]ethylidene]-4-methylidenecyclohexane-1,3-diol

C27H44O3 (416.329)


A hydroxycalciol that is calcidiol in which the pro-S hydrogen of calcidiol is replaced by a hydroxy group. It is the active form of vitamin D3, produced fom calciol via hydoxylation in the liver to form calcidiol, which is subsequently oxidised in the kidney to give calcitriol. A - Alimentary tract and metabolism > A11 - Vitamins > A11C - Vitamin a and d, incl. combinations of the two > A11CC - Vitamin d and analogues D002317 - Cardiovascular Agents > D014662 - Vasoconstrictor Agents > D002120 - Calcium Channel Agonists COVID info from clinicaltrial, clinicaltrials, clinical trial, clinical trials, COVID-19 Disease Map C274 - Antineoplastic Agent > C2122 - Cell Differentiating Agent > C1934 - Differentiation Inducer D018977 - Micronutrients > D014815 - Vitamins > D004100 - Dihydroxycholecalciferols D - Dermatologicals > D05 - Antipsoriatics > D05A - Antipsoriatics for topical use D018977 - Micronutrients > D014815 - Vitamins > D006887 - Hydroxycholecalciferols D000077264 - Calcium-Regulating Hormones and Agents D050071 - Bone Density Conservation Agents D049990 - Membrane Transport Modulators Corona-virus Coronavirus SARS-CoV-2 COVID-19 SARS-CoV COVID19 SARS2 SARS

   

(E)-3α-hydroxy-6-ethylidene-7-keto-5β-cholan-24-oic acid

(E)-3α-hydroxy-6-ethylidene-7-keto-5β-cholan-24-oic acid

C26H40O4 (416.2926)


   

(E/Z)-3α-hydroxy-6-ethylidene-7-keto-5β-cholan-24-oic acid

(E/Z)-3α-hydroxy-6-ethylidene-7-keto-5β-cholan-24-oic acid

C26H40O4 (416.2926)


   

Drostanolone Enanthate

Drostanolone Enanthate

C27H44O3 (416.329)


   

(1R,3R)-5-(2-((1R,3aS,7aR,E)-1-((2R,5S,Z)-6-hydroxy-5,6-dimethylhept-3-en-2-yl)-7a-methyloctahydro-4H-inden-4-ylidene)ethylidene)cyclohexane-1,3-diol

(1R,3R)-5-(2-((1R,3aS,7aR,E)-1-((2R,5S,Z)-6-hydroxy-5,6-dimethylhept-3-en-2-yl)-7a-methyloctahydro-4H-inden-4-ylidene)ethylidene)cyclohexane-1,3-diol

C27H44O3 (416.329)


   

Episarsasapogenin

(25R)-5alpha-Spirostan-3beta-ol

C27H44O3 (416.329)


Episarsasapogenin, also known as smilagenin or sarsasapogenin, (3beta,5beta,25s)-isomer, is a member of the class of compounds known as triterpenoids. Triterpenoids are terpene molecules containing six isoprene units. Episarsasapogenin is practically insoluble (in water) and an extremely weak acidic compound (based on its pKa). Episarsasapogenin can be found in fenugreek, which makes episarsasapogenin a potential biomarker for the consumption of this food product.

   

3-Hydroxypalmitoylcarnitine

3-Hydroxypalmitoylcarnitine

C23H46NO5+ (416.3376)


   

(24S)-7alpha,24-dihydroxycholest-4-en-3-one

(24S)-7alpha,24-dihydroxycholest-4-en-3-one

C27H44O3 (416.329)


7alpha,24-Dihydroxycholest-4-en-3-one with S-configuration at C-24.

   

(3beta)-3,25-Dihydroxycholest-5-en-7-one

(3beta)-3,25-Dihydroxycholest-5-en-7-one

C27H44O3 (416.329)


   

17-[(3,6-dideoxy-alpha-L-arabino-hexopyranosyl)oxy]heptadecanoic acid

17-[(3,6-dideoxy-alpha-L-arabino-hexopyranosyl)oxy]heptadecanoic acid

C23H44O6 (416.3138)


   

Plakortolide K

Plakortolide K

C26H40O4 (416.2926)


An organic heterobicyclic compound that is a cyclic peroxy compound isolated from the Australian marine sponge Plakinastrella clathrata.

   

(16R)-16-[(3,6-dideoxy-alpha-L-arabino-hexopyranosyl)oxy]heptadecanoic acid

(16R)-16-[(3,6-dideoxy-alpha-L-arabino-hexopyranosyl)oxy]heptadecanoic acid

C23H44O6 (416.3138)


   

(6S)-6-[(1R,3aS,4E,7aR)-4-[(2Z)-2-[(5R)-5-hydroxy-2-methylidenecyclohexylidene]ethylidene]-7a-methyl-2,3,3a,5,6,7-hexahydro-1H-inden-1-yl]-2-methylheptane-2,5-diol

(6S)-6-[(1R,3aS,4E,7aR)-4-[(2Z)-2-[(5R)-5-hydroxy-2-methylidenecyclohexylidene]ethylidene]-7a-methyl-2,3,3a,5,6,7-hexahydro-1H-inden-1-yl]-2-methylheptane-2,5-diol

C27H44O3 (416.329)


D018977 - Micronutrients > D014815 - Vitamins > D004100 - Dihydroxycholecalciferols D018977 - Micronutrients > D014815 - Vitamins > D006887 - Hydroxycholecalciferols

   

E160E

2,4,6,8,10,12,14,16-Heptadecaoctaenal, 2,6,11,15-tetramethyl-17-(2,6,6-trimethyl-1-cyclohexen-1-yl)-, (2E,4E,6E,8E,10E,12E,14E,16E)-

C30H40O (416.3079)


D020011 - Protective Agents > D000975 - Antioxidants > D002338 - Carotenoids β-Apo-8'-carotenal (Apocarotenal), a provitamin A carotenoid, is an inducer of CYPlA1 and CYPlA2 in rat. β-Apo-8'-carotenal is present in many fruits and vegetables[1]. β-Apo-8'-carotenal (Apocarotenal), a provitamin A carotenoid, is an inducer of CYPlA1 and CYPlA2 in rat. β-Apo-8'-carotenal is present in many fruits and vegetables[1].

   

24 25-Dihydroxy VD3

24,25-Dihydroxyvitamin D3

C27H44O3 (416.329)


24,25-Dihydroxyvitamin D (24R,25(OH)2D3) circulates in blood at concentrations about 1000 times higher than 1alpha,25(OH)2D3. 24-Hydroxylase is present in the proximal convoluted tubule cells of the kidney and in virtual all target cells of 1alpha,25(OH)2D3. Interestingly, 1alpha,25(OH)2D3 is a very strong inducer of 24-hydroxylase activity and 24R,25(OH)2D3 formationand is) also parathyroid hormone (PTH) regulates 24-hydroxylase activity but in a tissue specific manner, i.e. inhibitory in the kidney while a synergistic effect together with 1alpha,25(OH)2D3 is observed in osteoblasts. Generally, 24-hydroxylation has been considered the first step in the degradation pathway of 1alpha,25(OH)2D3 and 25-(OH)D3. However, through the past decades data have accumulated that 24R,25(OH)2D3 is not merely a degradation product but has effects on its own. Classic studies have demonstrated the significance of 24R,25(OH)2D3 for normal chicken egg hatchability and calcium and phosphorus homeostasis. More recently it became apparent that 24R,25(OH)2D3 also has distinct effects on cartilage in particular the resting zone cells. 24R,25(OH)2D3 stimulates osteocalcin synthesis in human osteoblasts. 24R,25(OH)2D3 plays a role in bone metabolism but that it acts in concert with 1alpha,25(OH)2D3 to obtain an optimal effect. (PMID: 11179746 ) [HMDB]

   

(24R,25S)-25,26-epoxy-1alpha,24-dihydroxy-27-norvitamin D3/(24R,25S)-25,26-epoxy-1alpha,24-dihydroxy-27-norcholecalciferol

(24R,25S)-25,26-epoxy-1alpha,24-dihydroxy-27-norvitamin D3/(24R,25S)-25,26-epoxy-1alpha,24-dihydroxy-27-norcholecalciferol

C26H40O4 (416.2926)


   

(5E)-(24R)-24,25-dihydroxy-[6,19,19-trideutrio]vitamin D3/(5E)-(24R)-24,25-dihydroxy-[6,19,19-trideutrio]cholecalciferol

(5E)-(24R)-24,25-dihydroxy-[6,19,19-trideutrio]vitamin D3/(5E)-(24R)-24,25-dihydroxy-[6,19,19-trideutrio]cholecalciferol

C27H44O3 (416.329)


   

(24S)-1alpha,24-dihydroxyvitamin D3/(24S)-1alpha,24-dihydroxycholecalciferol

(24S)-1alpha,24-dihydroxyvitamin D3/(24S)-1alpha,24-dihydroxycholecalciferol

C27H44O3 (416.329)


   

18,25-dihydroxyvitamin D3/18,25-dihydroxycholecalciferol

18,25-dihydroxyvitamin D3/18,25-dihydroxycholecalciferol

C27H44O3 (416.329)


   

23S,25-dihydroxyvitamin D3

23S,25-dihydroxyvitamin D3

C27H44O3 (416.329)


D018977 - Micronutrients > D014815 - Vitamins > D004100 - Dihydroxycholecalciferols D018977 - Micronutrients > D014815 - Vitamins > D006887 - Hydroxycholecalciferols

   

(25S)-3alpha-hydroxy-5alpha-cholest-7-en-26-oic acid

(25S)-3alpha-hydroxy-5alpha-cholest-7-en-26-oic acid

C27H44O3 (416.329)


A steroid acid that is 5alpha-cholest-7-en-26-oic acid that has S configuration at position 25 and is substituted by a hydroxy group at the 3alpha position. It is an endogenous ligand for DAF-12 in Caenorhabditis elegans.

   

Apo-8-lycopenal

Apo-8-lycopenal

C30H40O (416.3079)


D020011 - Protective Agents > D000975 - Antioxidants > D002338 - Carotenoids

   

(2E,4E,6E,8E,10E,12E,14E,16E,18E,20E)-2,6,10,15,19,23-hexamethyltetracosa-2,4,6,8,10,12,14,16,18,20,22-undecaen-1-ol

(2E,4E,6E,8E,10E,12E,14E,16E,18E,20E)-2,6,10,15,19,23-hexamethyltetracosa-2,4,6,8,10,12,14,16,18,20,22-undecaen-1-ol

C30H40O (416.3079)


   

(5Z,7E)-9,10-Secocholesta-5,7,10-triene-3,24,25-triol

(5Z,7E)-9,10-Secocholesta-5,7,10-triene-3,24,25-triol

C27H44O3 (416.329)


D018977 - Micronutrients > D014815 - Vitamins > D004100 - Dihydroxycholecalciferols D018977 - Micronutrients > D014815 - Vitamins > D006887 - Hydroxycholecalciferols D000077264 - Calcium-Regulating Hormones and Agents D050071 - Bone Density Conservation Agents

   

7 alpha,24-Dihydroxy-4-cholesten-3-one

7 alpha,24-Dihydroxy-4-cholesten-3-one

C27H44O3 (416.329)


   

[3-Carboxy-2-(16-hydroxyhexadecanoyloxy)propyl]-trimethylazanium

[3-Carboxy-2-(16-hydroxyhexadecanoyloxy)propyl]-trimethylazanium

C23H46NO5+ (416.3376)


   

6-[(4Z)-4-[(2E)-2-(5-hydroxy-2-methylidenecyclohexylidene)ethylidene]-7a-methyl-2,3,3a,5,6,7-hexahydro-1H-inden-1-yl]-2-methylheptane-1,2-diol

6-[(4Z)-4-[(2E)-2-(5-hydroxy-2-methylidenecyclohexylidene)ethylidene]-7a-methyl-2,3,3a,5,6,7-hexahydro-1H-inden-1-yl]-2-methylheptane-1,2-diol

C27H44O3 (416.329)


D018977 - Micronutrients > D014815 - Vitamins > D004100 - Dihydroxycholecalciferols D018977 - Micronutrients > D014815 - Vitamins > D006887 - Hydroxycholecalciferols

   

19-Nor-1-,25-dihydroxyvitamin D2

19-Nor-1-,25-dihydroxyvitamin D2

C27H44O3 (416.329)


   

[3-Carboxy-2-(2-hydroxyhexadecanoyloxy)propyl]-trimethylazanium

[3-Carboxy-2-(2-hydroxyhexadecanoyloxy)propyl]-trimethylazanium

C23H46NO5+ (416.3376)


   

[3-Carboxy-2-(3-hydroxyhexadecanoyloxy)propyl]-trimethylazanium

[3-Carboxy-2-(3-hydroxyhexadecanoyloxy)propyl]-trimethylazanium

C23H46NO5+ (416.3376)


   

Impurity A of Tacalcitol

Impurity A of Tacalcitol

C27H44O3 (416.329)


   

(1S)-3-[2-[(1R,7Ar)-7a-methyl-1-[(2R)-6-methylheptan-2-yl]-2,3,3a,5,6,7-hexahydro-1H-inden-4-ylidene]ethylidene]-1-hydroperoxy-4-methylidenecyclohexan-1-ol

(1S)-3-[2-[(1R,7Ar)-7a-methyl-1-[(2R)-6-methylheptan-2-yl]-2,3,3a,5,6,7-hexahydro-1H-inden-4-ylidene]ethylidene]-1-hydroperoxy-4-methylidenecyclohexan-1-ol

C27H44O3 (416.329)


   

[3-Carboxy-2-(14-carboxytetradecanoyloxy)propyl]-trimethylazanium

[3-Carboxy-2-(14-carboxytetradecanoyloxy)propyl]-trimethylazanium

C22H42NO6+ (416.3012)


   

[3-Carboxy-2-(5-hydroxyhexadecanoyloxy)propyl]-trimethylazanium

[3-Carboxy-2-(5-hydroxyhexadecanoyloxy)propyl]-trimethylazanium

C23H46NO5+ (416.3376)


   

[3-Carboxy-2-(7-hydroxyhexadecanoyloxy)propyl]-trimethylazanium

[3-Carboxy-2-(7-hydroxyhexadecanoyloxy)propyl]-trimethylazanium

C23H46NO5+ (416.3376)


   

[3-Carboxy-2-(8-hydroxyhexadecanoyloxy)propyl]-trimethylazanium

[3-Carboxy-2-(8-hydroxyhexadecanoyloxy)propyl]-trimethylazanium

C23H46NO5+ (416.3376)


   

[3-Carboxy-2-(9-hydroxyhexadecanoyloxy)propyl]-trimethylazanium

[3-Carboxy-2-(9-hydroxyhexadecanoyloxy)propyl]-trimethylazanium

C23H46NO5+ (416.3376)


   

[3-Carboxy-2-(10-hydroxyhexadecanoyloxy)propyl]-trimethylazanium

[3-Carboxy-2-(10-hydroxyhexadecanoyloxy)propyl]-trimethylazanium

C23H46NO5+ (416.3376)


   

[3-Carboxy-2-(11-hydroxyhexadecanoyloxy)propyl]-trimethylazanium

[3-Carboxy-2-(11-hydroxyhexadecanoyloxy)propyl]-trimethylazanium

C23H46NO5+ (416.3376)


   

[3-Carboxy-2-(12-hydroxyhexadecanoyloxy)propyl]-trimethylazanium

[3-Carboxy-2-(12-hydroxyhexadecanoyloxy)propyl]-trimethylazanium

C23H46NO5+ (416.3376)


   

[3-Carboxy-2-(13-hydroxyhexadecanoyloxy)propyl]-trimethylazanium

[3-Carboxy-2-(13-hydroxyhexadecanoyloxy)propyl]-trimethylazanium

C23H46NO5+ (416.3376)


   

[3-Carboxy-2-(6-hydroxyhexadecanoyloxy)propyl]-trimethylazanium

[3-Carboxy-2-(6-hydroxyhexadecanoyloxy)propyl]-trimethylazanium

C23H46NO5+ (416.3376)


   

20(S),25-dihydroxyvitamin D3

20(S),25-dihydroxyvitamin D3

C27H44O3 (416.329)


A hydroxycalciol that consists of vitamin D3 (calciol) carrying additional hydroxy groups at positions 20 (with S-configuration) and 25.

   

Methylene bispropionate

Methandriol dipropionate

C26H40O4 (416.2926)


C147908 - Hormone Therapy Agent > C548 - Therapeutic Hormone > C2360 - Anabolic Steroid Same as: D08197

   

(5alpha)-3-Oxocholestan-26-oic acid

(5alpha)-3-Oxocholestan-26-oic acid

C27H44O3 (416.329)


   

(20S,23)-dihydroxyvitamin D3

(20S,23)-dihydroxyvitamin D3

C27H44O3 (416.329)


A hydroxycalciol that consists of vitamin D3 (calciol) carrying additional hydroxy groups at positions 20 (with S-configuration) and 23.

   

(20S,24R)-dihydroxyvitamin D3

(20S,24R)-dihydroxyvitamin D3

C27H44O3 (416.329)


A hydroxycalciol that consists of vitamin D3 (calciol) carrying additional hydroxy groups at positions 20 (with S-configuration) and 24 (with R-configuration).

   

(20S,24S)-dihydroxyvitamin D3

(20S,24S)-dihydroxyvitamin D3

C27H44O3 (416.329)


A hydroxycalciol that consists of vitamin D3 (calciol) carrying additional hydroxy groups at positions 20 and 24 (both with S-configuration).

   

(24S,25)-epoxy-7alpha-hydroxycholesterol

(24S,25)-epoxy-7alpha-hydroxycholesterol

C27H44O3 (416.329)


An oxysterol that is (24S,25)-epoxycholesterol bearing a hydroxy substituent at the 7alpha-position.

   

Stachsterol

Stachsterol

C27H44O3 (416.329)


A cholestanoid that is cholest-4-ene substituted by hydroxy groups at positions 20 and 25 and an oxo group at position 3. Isolated from Stachyurus himalaicus, it exhibits cytotoxic activity against human Hela cell lines.

   

9,14,19,19,19-pentadeuterio-1alpha,25-dihydroxyprevitamin D3

9,14,19,19,19-pentadeuterio-1alpha,25-dihydroxyprevitamin D3

C27H44O3 (416.329)


   

N-arachidonoylleucinate

N-arachidonoylleucinate

C26H42NO3- (416.3165)


   

(7R,10R,13R)-7-hydroxy-17-[(2R)-7-hydroxy-6-methylheptan-2-yl]-10,13-dimethyl-1,2,6,7,8,9,11,12,14,15,16,17-dodecahydrocyclopenta[a]phenanthren-3-one

(7R,10R,13R)-7-hydroxy-17-[(2R)-7-hydroxy-6-methylheptan-2-yl]-10,13-dimethyl-1,2,6,7,8,9,11,12,14,15,16,17-dodecahydrocyclopenta[a]phenanthren-3-one

C27H44O3 (416.329)


   

16-[(2R,3R,5R,6S)-3,5-dihydroxy-6-methyloxan-2-yl]oxy-3-oxohexadecanoic acid

16-[(2R,3R,5R,6S)-3,5-dihydroxy-6-methyloxan-2-yl]oxy-3-oxohexadecanoic acid

C22H40O7 (416.2774)


   

(15R)-15-[(2R,3R,5R,6S)-3,5-dihydroxy-6-methyloxan-2-yl]oxy-3-oxohexadecanoic acid

(15R)-15-[(2R,3R,5R,6S)-3,5-dihydroxy-6-methyloxan-2-yl]oxy-3-oxohexadecanoic acid

C22H40O7 (416.2774)


   

5alpha-Spirostan-23-ol, (22S,23R,25R)-

5alpha-Spirostan-23-ol, (22S,23R,25R)-

C27H44O3 (416.329)


   

7alpha-Hydroxy-cholestenoic acid

7alpha-Hydroxy-cholestenoic acid

C27H44O3 (416.329)


   

(2R,3S)-8-[3-(dimethylamino)prop-1-ynyl]-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-2-[[methyl(propyl)amino]methyl]-3,4-dihydro-2H-pyrido[2,3-b][1,5]oxazocin-6-one

(2R,3S)-8-[3-(dimethylamino)prop-1-ynyl]-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-2-[[methyl(propyl)amino]methyl]-3,4-dihydro-2H-pyrido[2,3-b][1,5]oxazocin-6-one

C23H36N4O3 (416.2787)


   

(2S,3R)-8-[3-(dimethylamino)prop-1-ynyl]-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-2-[[methyl(propyl)amino]methyl]-3,4-dihydro-2H-pyrido[2,3-b][1,5]oxazocin-6-one

(2S,3R)-8-[3-(dimethylamino)prop-1-ynyl]-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-2-[[methyl(propyl)amino]methyl]-3,4-dihydro-2H-pyrido[2,3-b][1,5]oxazocin-6-one

C23H36N4O3 (416.2787)


   

(2S,3S)-8-[3-(dimethylamino)prop-1-ynyl]-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-2-[[methyl(propyl)amino]methyl]-3,4-dihydro-2H-pyrido[2,3-b][1,5]oxazocin-6-one

(2S,3S)-8-[3-(dimethylamino)prop-1-ynyl]-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-2-[[methyl(propyl)amino]methyl]-3,4-dihydro-2H-pyrido[2,3-b][1,5]oxazocin-6-one

C23H36N4O3 (416.2787)


   

(22R)-furost-5-en-3beta,22-diol

(22R)-furost-5-en-3beta,22-diol

C27H44O3 (416.329)


A 3beta-hydroxy-Delta(5)-steroid that is furostan carrying a double bond between positions 5-6 and hydroxy groups at positions 3beta and 22R.

   

1-[2-(Benzhydryloxy)ethyl]-4-(3-phenylpropyl)piperazinediium(2+)

1-[2-(Benzhydryloxy)ethyl]-4-(3-phenylpropyl)piperazinediium(2+)

C28H36N2O+2 (416.2827)


   

(24S,25R)-25,26-epoxy-1alpha,24-dihydroxy-27-norvitamin D3/(24S,25R)-25,26-epoxy-1alpha,24-dihydroxy-27-norcholecalciferol

(24S,25R)-25,26-epoxy-1alpha,24-dihydroxy-27-norvitamin D3/(24S,25R)-25,26-epoxy-1alpha,24-dihydroxy-27-norcholecalciferol

C26H40O4 (416.2926)


   

(7R,10R,13R)-7-hydroxy-17-[(2R)-5-hydroxy-6-methylheptan-2-yl]-10,13-dimethyl-1,2,6,7,8,9,11,12,14,15,16,17-dodecahydrocyclopenta[a]phenanthren-3-one

(7R,10R,13R)-7-hydroxy-17-[(2R)-5-hydroxy-6-methylheptan-2-yl]-10,13-dimethyl-1,2,6,7,8,9,11,12,14,15,16,17-dodecahydrocyclopenta[a]phenanthren-3-one

C27H44O3 (416.329)


   

(16S)-hydroxy-22-oxocholesterol

(16S)-hydroxy-22-oxocholesterol

C27H44O3 (416.329)


A C27-steroid that is cholesterol carrying a hydroxy group at position 16S and an oxo group at position 22.

   

[(2R)-3-carboxy-2-(14-carboxytetradecanoyloxy)propyl]-trimethylazanium

[(2R)-3-carboxy-2-(14-carboxytetradecanoyloxy)propyl]-trimethylazanium

C22H42NO6+ (416.3012)


   

Fahfa 18:5/8:0

Fahfa 18:5/8:0

C26H40O4 (416.2926)


   

Fahfa 4:0/22:5

Fahfa 4:0/22:5

C26H40O4 (416.2926)


   

Fahfa 22:5/4:0

Fahfa 22:5/4:0

C26H40O4 (416.2926)


   

Fahfa 20:5/6:0

Fahfa 20:5/6:0

C26H40O4 (416.2926)


   

2-Trimethylsilyloxyhexadecanoic acid trimethylsilyl ester

2-Trimethylsilyloxyhexadecanoic acid trimethylsilyl ester

C22H48O3Si2 (416.3142)


   

(5R,6R,7S,9S,13S)-5,7,9,13-tetramethylspiro[5-oxapentacyclo[10.8.0.02,9.04,8.013,18]icosane-6,2-oxane]-16-ol

(5R,6R,7S,9S,13S)-5,7,9,13-tetramethylspiro[5-oxapentacyclo[10.8.0.02,9.04,8.013,18]icosane-6,2-oxane]-16-ol

C27H44O3 (416.329)


   

(6R,7S,9S,13S,18S)-5,7,9,13-tetramethylspiro[5-oxapentacyclo[10.8.0.02,9.04,8.013,18]icosane-6,2-oxane]-16-ol

(6R,7S,9S,13S,18S)-5,7,9,13-tetramethylspiro[5-oxapentacyclo[10.8.0.02,9.04,8.013,18]icosane-6,2-oxane]-16-ol

C27H44O3 (416.329)


   

[1-carboxy-3-[3-[(E)-dodec-5-enoyl]oxy-2-hydroxypropoxy]propyl]-trimethylazanium

[1-carboxy-3-[3-[(E)-dodec-5-enoyl]oxy-2-hydroxypropoxy]propyl]-trimethylazanium

C22H42NO6+ (416.3012)


   

Apocarotenal

2,4,6,8,10,12,14,16-Heptadecaoctaenal, 2,6,11,15-tetramethyl-17-(2,6,6-trimethyl-1-cyclohexen-1-yl)-, (2E,4E,6E,8E,10E,12E,14E,16E)-

C30H40O (416.3079)


8-apo-beta,psi-caroten-8-al is an apo carotenoid triterpenoid compound arising from oxidative degradation of the beta,beta-carotene skeleton at the 8-position. It is an enal and an apo carotenoid triterpenoid. Apocarotenal is a natural product found in Dracaena draco, Palisota barteri, and other organisms with data available. D020011 - Protective Agents > D000975 - Antioxidants > D002338 - Carotenoids β-Apo-8'-carotenal (Apocarotenal), a provitamin A carotenoid, is an inducer of CYPlA1 and CYPlA2 in rat. β-Apo-8'-carotenal is present in many fruits and vegetables[1]. β-Apo-8'-carotenal (Apocarotenal), a provitamin A carotenoid, is an inducer of CYPlA1 and CYPlA2 in rat. β-Apo-8'-carotenal is present in many fruits and vegetables[1].

   

Secalciferol

(24R)-24,25-Dihydroxycalciol

C27H44O3 (416.329)


D018977 - Micronutrients > D014815 - Vitamins > D004100 - Dihydroxycholecalciferols D018977 - Micronutrients > D014815 - Vitamins > D006887 - Hydroxycholecalciferols D000077264 - Calcium-Regulating Hormones and Agents D050071 - Bone Density Conservation Agents

   

7alpha,26-dihydroxycholest-4-en-3-one

7alpha,26-dihydroxycholest-4-en-3-one

C27H44O3 (416.329)


   

7alpha,25-Dihydroxy-4-cholesten-3-one

7alpha,25-Dihydroxy-4-cholesten-3-one

C27H44O3 (416.329)


A cholestanoid that is 4-cholesten-3-one carrying two additional hydroxy substituents at positions 7alpha and 25.

   

3beta-hydroxy-5-cholestenoic acid

3beta-hydroxy-5-cholestenoic acid

C27H44O3 (416.329)


   

7alpha,24-dihydroxycholest-4-en-3-one

7alpha,24-dihydroxycholest-4-en-3-one

C27H44O3 (416.329)


   

(25S)-cholestenoic acid

(25S)-cholestenoic acid

C27H44O3 (416.329)


A cholestanoid that is (25S)-cholest-5-en-26-oic acid bearing a 3beta-hydroxy substituent.

   

Octadecyl p-coumarate

Octadecyl p-coumarate

C27H44O3 (416.329)


   

25,26-dihydroxyvitamin D

25,26-dihydroxyvitamin D

C27H44O3 (416.329)


   

(25R)-7alpha,26-dihydroxycholest-4-en-3-one

(25R)-7alpha,26-dihydroxycholest-4-en-3-one

C27H44O3 (416.329)


An oxysterol that is cholesterol which is substituted by an oxo group at position 3 and hydroxy groups at positions 7alpha and 26. It has R-configuration at position 25.

   

beta-apo-8-carotenal

beta-apo-8-carotenal

C30H40O (416.3079)


   

(25R)-3beta,4beta-dihydroxycholest-5-en-26-al

(25R)-3beta,4beta-dihydroxycholest-5-en-26-al

C27H44O3 (416.329)


A 26-oxo steroid resulting from the oxidation of the terminal methyl group of 4beta,26-dihydroxycholesterol to the corresponding aldehyde.

   

(25R)-3beta,26-dihydroxycholest-5-en-7-one

(25R)-3beta,26-dihydroxycholest-5-en-7-one

C27H44O3 (416.329)


An oxysterol that is 7-ketocholesterol which is substituted by a hydroxy group at position 26 and has R-configuration at position 25.

   

(5alpha,25S)-3-oxocholestan-26-oic acid

(5alpha,25S)-3-oxocholestan-26-oic acid

C27H44O3 (416.329)


   

20S-Hydroxy-5-alpha-cholestane-3,16-dione

20S-Hydroxy-5-alpha-cholestane-3,16-dione

C27H44O3 (416.329)


   

7alpha-hydroperoxy-cholesta-5,8-dien-3beta-ol

7alpha-hydroperoxy-cholesta-5,8-dien-3beta-ol

C27H44O3 (416.329)


   

3beta-Hydroxycholest-5-en-26-oic acid

3beta-Hydroxycholest-5-en-26-oic acid

C27H44O3 (416.329)


A steroid acid resulting from the oxidation of one of the terminal methyl groups of cholesterol to the corresponding aldehyde.

   

(25R)-3beta-hydroxycholest-5-en-26-oic acid

(25R)-3beta-hydroxycholest-5-en-26-oic acid

C27H44O3 (416.329)


A 3beta-hydroxycholest-5-en-26-oic acid in which the stereocentre at position 25 has R-configuration.

   

Hydroxyheptacosapentaenoic acid

Hydroxyheptacosapentaenoic acid

C27H44O3 (416.329)


   

NA-Orn 20:5(5Z,8Z,11Z,14Z,17Z)

NA-Orn 20:5(5Z,8Z,11Z,14Z,17Z)

C25H40N2O3 (416.3039)


   

FAHFA 10:0/O-16:5

FAHFA 10:0/O-16:5

C26H40O4 (416.2926)


   

FAHFA 10:1/O-16:4

FAHFA 10:1/O-16:4

C26H40O4 (416.2926)


   

FAHFA 10:2/O-16:3

FAHFA 10:2/O-16:3

C26H40O4 (416.2926)


   

FAHFA 10:3/O-16:2

FAHFA 10:3/O-16:2

C26H40O4 (416.2926)


   

FAHFA 11:0/O-15:5

FAHFA 11:0/O-15:5

C26H40O4 (416.2926)


   

FAHFA 11:1/O-15:4

FAHFA 11:1/O-15:4

C26H40O4 (416.2926)


   

FAHFA 11:2/O-15:3

FAHFA 11:2/O-15:3

C26H40O4 (416.2926)


   

FAHFA 11:3/O-15:2

FAHFA 11:3/O-15:2

C26H40O4 (416.2926)


   

FAHFA 12:1/O-14:4

FAHFA 12:1/O-14:4

C26H40O4 (416.2926)


   

FAHFA 12:2/O-14:3

FAHFA 12:2/O-14:3

C26H40O4 (416.2926)


   

FAHFA 12:3/O-14:2

FAHFA 12:3/O-14:2

C26H40O4 (416.2926)


   

FAHFA 12:4/O-14:1

FAHFA 12:4/O-14:1

C26H40O4 (416.2926)


   

FAHFA 13:1/O-13:4

FAHFA 13:1/O-13:4

C26H40O4 (416.2926)


   

FAHFA 13:2/O-13:3

FAHFA 13:2/O-13:3

C26H40O4 (416.2926)


   

FAHFA 13:3/O-13:2

FAHFA 13:3/O-13:2

C26H40O4 (416.2926)


   

FAHFA 13:4/O-13:1

FAHFA 13:4/O-13:1

C26H40O4 (416.2926)


   

FAHFA 14:1/O-12:4

FAHFA 14:1/O-12:4

C26H40O4 (416.2926)


   

FAHFA 14:2/O-12:3

FAHFA 14:2/O-12:3

C26H40O4 (416.2926)


   

FAHFA 14:3/O-12:2

FAHFA 14:3/O-12:2

C26H40O4 (416.2926)


   

FAHFA 14:4/O-12:1

FAHFA 14:4/O-12:1

C26H40O4 (416.2926)


   

FAHFA 15:2/O-11:3

FAHFA 15:2/O-11:3

C26H40O4 (416.2926)


   

FAHFA 15:3/O-11:2

FAHFA 15:3/O-11:2

C26H40O4 (416.2926)


   

FAHFA 15:4/O-11:1

FAHFA 15:4/O-11:1

C26H40O4 (416.2926)


   

FAHFA 15:5/O-11:0

FAHFA 15:5/O-11:0

C26H40O4 (416.2926)


   

FAHFA 16:2/O-10:3

FAHFA 16:2/O-10:3

C26H40O4 (416.2926)


   

FAHFA 16:3/O-10:2

FAHFA 16:3/O-10:2

C26H40O4 (416.2926)


   

FAHFA 16:4/O-10:1

FAHFA 16:4/O-10:1

C26H40O4 (416.2926)


   

FAHFA 16:5/O-10:0

FAHFA 16:5/O-10:0

C26H40O4 (416.2926)


   

FAHFA 17:2/O-9:3

FAHFA 17:2/O-9:3

C26H40O4 (416.2926)


   

FAHFA 17:3/O-9:2

FAHFA 17:3/O-9:2

C26H40O4 (416.2926)


   

FAHFA 17:4/O-9:1

FAHFA 17:4/O-9:1

C26H40O4 (416.2926)


   

FAHFA 17:5/O-9:0

FAHFA 17:5/O-9:0

C26H40O4 (416.2926)


   

FAHFA 18:3/O-8:2

FAHFA 18:3/O-8:2

C26H40O4 (416.2926)


   

FAHFA 18:4/O-8:1

FAHFA 18:4/O-8:1

C26H40O4 (416.2926)


   

FAHFA 18:5/O-8:0

FAHFA 18:5/O-8:0

C26H40O4 (416.2926)


   

FAHFA 20:5(5Z,8Z,11Z,14Z,17Z)/3O-6:0

FAHFA 20:5(5Z,8Z,11Z,14Z,17Z)/3O-6:0

C26H40O4 (416.2926)


   

FAHFA 26:5;O

FAHFA 26:5;O

C26H40O4 (416.2926)


   

FAHFA 8:0/O-18:5

FAHFA 8:0/O-18:5

C26H40O4 (416.2926)


   

FAHFA 8:1/O-18:4

FAHFA 8:1/O-18:4

C26H40O4 (416.2926)


   

FAHFA 8:2/O-18:3

FAHFA 8:2/O-18:3

C26H40O4 (416.2926)


   

FAHFA 9:0/O-17:5

FAHFA 9:0/O-17:5

C26H40O4 (416.2926)


   

FAHFA 9:1/O-17:4

FAHFA 9:1/O-17:4

C26H40O4 (416.2926)


   

FAHFA 9:2/O-17:3

FAHFA 9:2/O-17:3

C26H40O4 (416.2926)


   

FAHFA 9:3/O-17:2

FAHFA 9:3/O-17:2

C26H40O4 (416.2926)


   

Diepoxy-cholesterol

Diepoxy-cholesterol

C27H44O3 (416.329)


   

Trideoxyecdysone

Trideoxyecdysone

C27H44O3 (416.329)


   
   

2-[2-(4,6-dihydroxy-8a-methyl-1-oxo-4,4a,5,6,7,8-hexahydronaphthalen-2-yl)-1-methyl-5-(5-methylhex-3-en-2-yl)cyclopentyl]acetaldehyde

2-[2-(4,6-dihydroxy-8a-methyl-1-oxo-4,4a,5,6,7,8-hexahydronaphthalen-2-yl)-1-methyl-5-(5-methylhex-3-en-2-yl)cyclopentyl]acetaldehyde

C26H40O4 (416.2926)


   

(1r,5as,5br,7as,11as,11br,13r,13as,13br)-13-hydroxy-1-methoxy-5b,8,8,11a,13a-pentamethyl-1h,5h,5ah,6h,7h,7ah,9h,10h,11h,11bh,12h,13h,13bh-chryseno[1,2-c]furan-3-one

(1r,5as,5br,7as,11as,11br,13r,13as,13br)-13-hydroxy-1-methoxy-5b,8,8,11a,13a-pentamethyl-1h,5h,5ah,6h,7h,7ah,9h,10h,11h,11bh,12h,13h,13bh-chryseno[1,2-c]furan-3-one

C26H40O4 (416.2926)


   

(5s)-5-[(1s,3ar,3br,5ar,7s,9ar,9br,11ar)-7-hydroxy-3a,3b,6,6,9a-pentamethyl-dodecahydro-1h-cyclopenta[a]phenanthren-1-yl]-5-methyloxolan-2-one

(5s)-5-[(1s,3ar,3br,5ar,7s,9ar,9br,11ar)-7-hydroxy-3a,3b,6,6,9a-pentamethyl-dodecahydro-1h-cyclopenta[a]phenanthren-1-yl]-5-methyloxolan-2-one

C27H44O3 (416.329)


   

n-[4-amino-6-({3-amino-6-[(methylamino)methyl]oxan-2-yl}oxy)-2-hydroxy-3-methoxycyclohexyl]-2-methanimidamido-n-methylacetamide

n-[4-amino-6-({3-amino-6-[(methylamino)methyl]oxan-2-yl}oxy)-2-hydroxy-3-methoxycyclohexyl]-2-methanimidamido-n-methylacetamide

C18H36N6O5 (416.2747)


   

7',9',13'-trimethyl-5'-oxaspiro[oxane-2,6'-pentacyclo[10.8.0.0²,⁹.0⁴,⁸.0¹³,¹⁸]icosan]-18'-ene-10',16'-diol

7',9',13'-trimethyl-5'-oxaspiro[oxane-2,6'-pentacyclo[10.8.0.0²,⁹.0⁴,⁸.0¹³,¹⁸]icosan]-18'-ene-10',16'-diol

C26H40O4 (416.2926)


   

13-(2-hydroxy-6-methyl-4-oxohept-5-en-2-yl)-5,9,10-trimethyl-2-oxatetracyclo[7.6.1.0⁵,¹⁶.0¹⁰,¹⁴]hexadecan-3-one

13-(2-hydroxy-6-methyl-4-oxohept-5-en-2-yl)-5,9,10-trimethyl-2-oxatetracyclo[7.6.1.0⁵,¹⁶.0¹⁰,¹⁴]hexadecan-3-one

C26H40O4 (416.2926)


   

(3r,4as,7as)-3-(2,4-dimethyl-10-phenyldecyl)-3,4a-dimethyl-dihydro-4h-furo[3,2-c][1,2]dioxin-6-one

(3r,4as,7as)-3-(2,4-dimethyl-10-phenyldecyl)-3,4a-dimethyl-dihydro-4h-furo[3,2-c][1,2]dioxin-6-one

C26H40O4 (416.2926)


   

3-{1-isopropyl-3b,5a,9b,11a-tetramethyl-7-oxo-dodecahydrocyclopenta[a]phenanthren-6-yl}propanoic acid

3-{1-isopropyl-3b,5a,9b,11a-tetramethyl-7-oxo-dodecahydrocyclopenta[a]phenanthren-6-yl}propanoic acid

C27H44O3 (416.329)


   

methyl 5,9-dimethyl-15-[(3-methylbutanoyl)oxy]-14-methylidenetetracyclo[11.2.1.0¹,¹⁰.0⁴,⁹]hexadecane-5-carboxylate

methyl 5,9-dimethyl-15-[(3-methylbutanoyl)oxy]-14-methylidenetetracyclo[11.2.1.0¹,¹⁰.0⁴,⁹]hexadecane-5-carboxylate

C26H40O4 (416.2926)


   

1-[(2r,4e)-6-hydroperoxy-6-methylhept-4-en-2-yl]-9a,11a-dimethyl-1h,2h,3h,3ah,3bh,4h,6h,7h,8h,9h,9bh,10h,11h-cyclopenta[a]phenanthren-7-ol

1-[(2r,4e)-6-hydroperoxy-6-methylhept-4-en-2-yl]-9a,11a-dimethyl-1h,2h,3h,3ah,3bh,4h,6h,7h,8h,9h,9bh,10h,11h-cyclopenta[a]phenanthren-7-ol

C27H44O3 (416.329)


   

7,9b-dihydroxy-9a,11a-dimethyl-1-(6-methylheptan-2-yl)-1h,2h,3h,3ah,5ah,6h,7h,8h,9h,10h,11h-cyclopenta[a]phenanthren-5-one

7,9b-dihydroxy-9a,11a-dimethyl-1-(6-methylheptan-2-yl)-1h,2h,3h,3ah,5ah,6h,7h,8h,9h,10h,11h-cyclopenta[a]phenanthren-5-one

C27H44O3 (416.329)


   

(1r,3ar,5s,5ar,7s,9ar,11ar)-9a,11a-dimethyl-1-[(2r)-6-methylhept-5-en-2-yl]-1h,2h,3h,3ah,4h,5h,6h,7h,8h,9h,10h,11h-cyclopenta[a]phenanthrene-5,5a,7-triol

(1r,3ar,5s,5ar,7s,9ar,11ar)-9a,11a-dimethyl-1-[(2r)-6-methylhept-5-en-2-yl]-1h,2h,3h,3ah,4h,5h,6h,7h,8h,9h,10h,11h-cyclopenta[a]phenanthrene-5,5a,7-triol

C27H44O3 (416.329)


   

(1s,3'r,3as,5ar,6s,7s,9as,11as)-7-hydroxy-6-(hydroxymethyl)-3',3a,6,9a,11a-pentamethyl-2,3,4,5,5a,7,8,9,10,11-decahydrospiro[cyclopenta[a]phenanthrene-1,2'-oxolan]-5'-one

(1s,3'r,3as,5ar,6s,7s,9as,11as)-7-hydroxy-6-(hydroxymethyl)-3',3a,6,9a,11a-pentamethyl-2,3,4,5,5a,7,8,9,10,11-decahydrospiro[cyclopenta[a]phenanthrene-1,2'-oxolan]-5'-one

C26H40O4 (416.2926)


   

(1'r,2s,2's,3s,4'r,5s,8's,9's,12'r,13's,16's,18'r)-3,5,9',13'-tetramethyl-5'-oxaspiro[oxane-2,6'-pentacyclo[10.8.0.0²,⁹.0⁴,⁸.0¹³,¹⁸]icosan]-16'-ol

(1'r,2s,2's,3s,4'r,5s,8's,9's,12'r,13's,16's,18'r)-3,5,9',13'-tetramethyl-5'-oxaspiro[oxane-2,6'-pentacyclo[10.8.0.0²,⁹.0⁴,⁸.0¹³,¹⁸]icosan]-16'-ol

C27H44O3 (416.329)


   

(2r,3r)-2-[(3s,5r)-3,5-dimethyl-2-methylidene-6-{[(2r,3r)-3-(4-methylphenyl)oxiran-2-yl]methyl}hept-6-en-1-yl]-3-(4-methylphenyl)oxirane

(2r,3r)-2-[(3s,5r)-3,5-dimethyl-2-methylidene-6-{[(2r,3r)-3-(4-methylphenyl)oxiran-2-yl]methyl}hept-6-en-1-yl]-3-(4-methylphenyl)oxirane

C29H36O2 (416.2715)


   

3-[(1r,3ar,3bs,5ar,6s,9as,9br,11ar)-1-isopropyl-3b,5a,9b,11a-tetramethyl-7-oxo-dodecahydrocyclopenta[a]phenanthren-6-yl]propanoic acid

3-[(1r,3ar,3bs,5ar,6s,9as,9br,11ar)-1-isopropyl-3b,5a,9b,11a-tetramethyl-7-oxo-dodecahydrocyclopenta[a]phenanthren-6-yl]propanoic acid

C27H44O3 (416.329)


   

5-{7-hydroxy-3a,3b,6,6,9a-pentamethyl-dodecahydro-1h-cyclopenta[a]phenanthren-1-yl}-5-methyloxolan-2-one

5-{7-hydroxy-3a,3b,6,6,9a-pentamethyl-dodecahydro-1h-cyclopenta[a]phenanthren-1-yl}-5-methyloxolan-2-one

C27H44O3 (416.329)


   

(1'r,2r,2's,4'r,5r,7'r,8'r,9's,12's,13's,16's,18'r)-5,7',9',13'-tetramethyl-5'-oxaspiro[oxane-2,6'-pentacyclo[10.8.0.0²,⁹.0⁴,⁸.0¹³,¹⁸]icosan]-16'-ol

(1'r,2r,2's,4'r,5r,7'r,8'r,9's,12's,13's,16's,18'r)-5,7',9',13'-tetramethyl-5'-oxaspiro[oxane-2,6'-pentacyclo[10.8.0.0²,⁹.0⁴,⁸.0¹³,¹⁸]icosan]-16'-ol

C27H44O3 (416.329)


   

(1r,2s,5as,9ar,11as)-2-hydroxy-9a,11a-dimethyl-1-[(2r)-6-methylheptan-2-yl]-dodecahydro-1h-cyclopenta[a]phenanthrene-5,7-dione

(1r,2s,5as,9ar,11as)-2-hydroxy-9a,11a-dimethyl-1-[(2r)-6-methylheptan-2-yl]-dodecahydro-1h-cyclopenta[a]phenanthrene-5,7-dione

C27H44O3 (416.329)


   

18-hydroxy-kauran16-en-19-oicacid

NA

C27H44O3 (416.329)


{"Ingredient_id": "HBIN002136","Ingredient_name": "18-hydroxy-kauran16-en-19-oicacid","Alias": "NA","Ingredient_formula": "C27H44O3","Ingredient_Smile": "CC(CCCC(C)C(=O)O)C1CCC2C1(CCC3C2CC=C4C3(CCC(C4)O)C)C","Ingredient_weight": "NA","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "37462","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "NA","DrugBank_id": "NA"}

   

2-n-pentadecyl-5,7-dihydroxy-6,8-dimethyl chromone

2-n-pentadecyl-5,7-dihydroxy-6,8-dimethylchromone

C26H40O4 (416.2926)


{"Ingredient_id": "HBIN006151","Ingredient_name": "2-n-pentadecyl-5,7-dihydroxy-6,8-dimethyl chromone","Alias": "2-n-pentadecyl-5,7-dihydroxy-6,8-dimethylchromone","Ingredient_formula": "C26H40O4","Ingredient_Smile": "Not Available","Ingredient_weight": "416.66","OB_score": "3.217095847","CAS_id": "NA","SymMap_id": "SMIT00862","TCMID_id": "16821","TCMSP_id": "MOL006579","TCM_ID_id": "NA","PubChem_id": "NA","DrugBank_id": "NA"}

   

n-(4-amino-3-{[3-amino-6-(1-aminoethyl)oxan-2-yl]oxy}-2-hydroxy-6-methoxycyclohexyl)-2-methanimidamido-n-methylacetamide

n-(4-amino-3-{[3-amino-6-(1-aminoethyl)oxan-2-yl]oxy}-2-hydroxy-6-methoxycyclohexyl)-2-methanimidamido-n-methylacetamide

C18H36N6O5 (416.2747)


   

1-(3-hydroxy-6-methylhept-5-en-2-yl)-9a,11a-dimethyl-1h,2h,3h,3ah,5h,5ah,6h,7h,8h,9h,9bh,10h,11h-cyclopenta[a]phenanthrene-6,7-diol

1-(3-hydroxy-6-methylhept-5-en-2-yl)-9a,11a-dimethyl-1h,2h,3h,3ah,5h,5ah,6h,7h,8h,9h,9bh,10h,11h-cyclopenta[a]phenanthrene-6,7-diol

C27H44O3 (416.329)


   

17-(1-hydroxyethyl)-10-(hydroxymethyl)-2,6,6,20-tetramethyl-14-oxapentacyclo[11.6.1.0²,¹¹.0⁵,¹⁰.0¹⁶,²⁰]icos-17-en-15-one

17-(1-hydroxyethyl)-10-(hydroxymethyl)-2,6,6,20-tetramethyl-14-oxapentacyclo[11.6.1.0²,¹¹.0⁵,¹⁰.0¹⁶,²⁰]icos-17-en-15-one

C26H40O4 (416.2926)


   

2-oxo-2-phenylethyl 11-cycloheptyl-2-hydroxyundecanoate

2-oxo-2-phenylethyl 11-cycloheptyl-2-hydroxyundecanoate

C26H40O4 (416.2926)


   

13-hydroxy-11a-(hydroxymethyl)-3,5b,8,8,13a-pentamethyl-3h,4h,5h,5ah,6h,7h,7ah,9h,10h,11h,11bh,12h,13h-chryseno[1,2-c]furan-1-one

13-hydroxy-11a-(hydroxymethyl)-3,5b,8,8,13a-pentamethyl-3h,4h,5h,5ah,6h,7h,7ah,9h,10h,11h,11bh,12h,13h-chryseno[1,2-c]furan-1-one

C26H40O4 (416.2926)


   

(1r,4s,13r,16e,19s)-4,15,15,19-tetramethyl-5,20-dioxapentacyclo[17.8.0.0⁴,¹³.0⁶,¹¹.0²¹,²⁶]heptacosa-6,8,10,16,21,23,25-heptaene

(1r,4s,13r,16e,19s)-4,15,15,19-tetramethyl-5,20-dioxapentacyclo[17.8.0.0⁴,¹³.0⁶,¹¹.0²¹,²⁶]heptacosa-6,8,10,16,21,23,25-heptaene

C29H36O2 (416.2715)


   

3-(5-hydroxy-2,6-dimethyl-7-oxoocta-1,3-dien-1-yl)-4-methyl-5-(6-methyldeca-2,4-dien-2-yl)oxolan-2-one

3-(5-hydroxy-2,6-dimethyl-7-oxoocta-1,3-dien-1-yl)-4-methyl-5-(6-methyldeca-2,4-dien-2-yl)oxolan-2-one

C26H40O4 (416.2926)


   

(1r,2r,5s,7s,9r,10r,11r,12r,15r,16r)-2,16-dimethyl-15-[(2r)-6-methylhept-5-en-2-yl]-8-oxapentacyclo[9.7.0.0²,⁷.0⁷,⁹.0¹²,¹⁶]octadecane-5,10-diol

(1r,2r,5s,7s,9r,10r,11r,12r,15r,16r)-2,16-dimethyl-15-[(2r)-6-methylhept-5-en-2-yl]-8-oxapentacyclo[9.7.0.0²,⁷.0⁷,⁹.0¹²,¹⁶]octadecane-5,10-diol

C27H44O3 (416.329)


   

(5s)-5-[(1r,3ar,3br,5ar,7r,9ar,9br,11as)-7-hydroxy-3a,3b,6,6,9a-pentamethyl-dodecahydro-1h-cyclopenta[a]phenanthren-1-yl]-5-methyloxolan-2-one

(5s)-5-[(1r,3ar,3br,5ar,7r,9ar,9br,11as)-7-hydroxy-3a,3b,6,6,9a-pentamethyl-dodecahydro-1h-cyclopenta[a]phenanthren-1-yl]-5-methyloxolan-2-one

C27H44O3 (416.329)


   

5-[12-(4-hydroxyphenyl)dodecyl]-5,6a-dimethyl-dihydro-3h-furo[3,2-b]furan-2-one

5-[12-(4-hydroxyphenyl)dodecyl]-5,6a-dimethyl-dihydro-3h-furo[3,2-b]furan-2-one

C26H40O4 (416.2926)


   

methyl (2e)-5-[(1s,2r,4s,4ar,8ar)-1,2,4a,5-tetramethyl-4-{[(2z)-2-methylbut-2-enoyl]oxy}-2,3,4,7,8,8a-hexahydronaphthalen-1-yl]-3-methylpent-2-enoate

methyl (2e)-5-[(1s,2r,4s,4ar,8ar)-1,2,4a,5-tetramethyl-4-{[(2z)-2-methylbut-2-enoyl]oxy}-2,3,4,7,8,8a-hexahydronaphthalen-1-yl]-3-methylpent-2-enoate

C26H40O4 (416.2926)


   

8-formyl-9-hydroxy-1,1,4a,6a,10b-pentamethyl-2,3,4,4b,5,6,9,10,10a,11,12,12a-dodecahydrochrysen-6-yl acetate

8-formyl-9-hydroxy-1,1,4a,6a,10b-pentamethyl-2,3,4,4b,5,6,9,10,10a,11,12,12a-dodecahydrochrysen-6-yl acetate

C26H40O4 (416.2926)


   

1-(2-hydroxy-6-methylheptan-2-yl)-9a,11a-dimethyl-dodecahydro-1h-cyclopenta[a]phenanthrene-2,7-dione

1-(2-hydroxy-6-methylheptan-2-yl)-9a,11a-dimethyl-dodecahydro-1h-cyclopenta[a]phenanthrene-2,7-dione

C27H44O3 (416.329)


   

3-(4-hydroxyphenyl)prop-2-en-1-yl octadecanoate

3-(4-hydroxyphenyl)prop-2-en-1-yl octadecanoate

C27H44O3 (416.329)


   

(1r,2r,5r,6r,9r,10r,13s,15r)-6,10-dimethyl-5-[(2r)-6-methylheptan-2-yl]-16,17-dioxapentacyclo[13.2.2.0¹,⁹.0²,⁶.0¹⁰,¹⁵]nonadec-18-en-13-ol

(1r,2r,5r,6r,9r,10r,13s,15r)-6,10-dimethyl-5-[(2r)-6-methylheptan-2-yl]-16,17-dioxapentacyclo[13.2.2.0¹,⁹.0²,⁶.0¹⁰,¹⁵]nonadec-18-en-13-ol

C27H44O3 (416.329)


   

n-[(1s,2r,3r,4s,6s)-4-amino-3-{[(2r,3r,6s)-3-amino-6-[(methylamino)methyl]oxan-2-yl]oxy}-2-hydroxy-6-methoxycyclohexyl]-2-methanimidamido-n-methylacetamide

n-[(1s,2r,3r,4s,6s)-4-amino-3-{[(2r,3r,6s)-3-amino-6-[(methylamino)methyl]oxan-2-yl]oxy}-2-hydroxy-6-methoxycyclohexyl]-2-methanimidamido-n-methylacetamide

C18H36N6O5 (416.2747)


   

(1'r,2r,2's,4's,5r,7's,8'r,9's,12's,13's,16'r,18's)-5,7',9',13'-tetramethyl-5'-oxaspiro[oxane-2,6'-pentacyclo[10.8.0.0²,⁹.0⁴,⁸.0¹³,¹⁸]icosan]-16'-ol

(1'r,2r,2's,4's,5r,7's,8'r,9's,12's,13's,16'r,18's)-5,7',9',13'-tetramethyl-5'-oxaspiro[oxane-2,6'-pentacyclo[10.8.0.0²,⁹.0⁴,⁸.0¹³,¹⁸]icosan]-16'-ol

C27H44O3 (416.329)


   

7-hydroxy-6-(hydroxymethyl)-3',3a,6,9a,11a-pentamethyl-2,3,4,5,5a,7,8,9,10,11-decahydrospiro[cyclopenta[a]phenanthrene-1,2'-oxolan]-5'-one

7-hydroxy-6-(hydroxymethyl)-3',3a,6,9a,11a-pentamethyl-2,3,4,5,5a,7,8,9,10,11-decahydrospiro[cyclopenta[a]phenanthrene-1,2'-oxolan]-5'-one

C26H40O4 (416.2926)


   

(1r,3ar,5r,5as,7s,9as,9bs,11ar)-9a,11a-dimethyl-1-[(2r,3e)-6-methylhept-3-en-2-yl]-1h,2h,3h,3ah,5h,5ah,6h,7h,8h,9h,10h,11h-cyclopenta[a]phenanthrene-5,7,9b-triol

(1r,3ar,5r,5as,7s,9as,9bs,11ar)-9a,11a-dimethyl-1-[(2r,3e)-6-methylhept-3-en-2-yl]-1h,2h,3h,3ah,5h,5ah,6h,7h,8h,9h,10h,11h-cyclopenta[a]phenanthrene-5,7,9b-triol

C27H44O3 (416.329)


   

n-[(1s,2r,3r,4r,6s)-4-amino-3-{[(2r,3r,6s)-3-amino-6-[(methylamino)methyl]oxan-2-yl]oxy}-2-hydroxy-6-methoxycyclohexyl]-2-methanimidamido-n-methylacetamide

n-[(1s,2r,3r,4r,6s)-4-amino-3-{[(2r,3r,6s)-3-amino-6-[(methylamino)methyl]oxan-2-yl]oxy}-2-hydroxy-6-methoxycyclohexyl]-2-methanimidamido-n-methylacetamide

C18H36N6O5 (416.2747)


   

2-heptadecyl-5,7-dihydroxychromen-4-one

2-heptadecyl-5,7-dihydroxychromen-4-one

C26H40O4 (416.2926)


   

3-[(1r,3ar,3bs,5as,6s,9as,9br,11ar)-1-isopropyl-3b,5a,9b,11a-tetramethyl-7-oxo-dodecahydrocyclopenta[a]phenanthren-6-yl]propanoic acid

3-[(1r,3ar,3bs,5as,6s,9as,9br,11ar)-1-isopropyl-3b,5a,9b,11a-tetramethyl-7-oxo-dodecahydrocyclopenta[a]phenanthren-6-yl]propanoic acid

C27H44O3 (416.329)


   

(1r,2s,9ar,11s,11as)-2,11-dihydroxy-9a,11a-dimethyl-1-[(2r)-6-methylheptan-2-yl]-1h,2h,3h,3ah,3bh,4h,5h,8h,9h,9bh,10h,11h-cyclopenta[a]phenanthren-7-one

(1r,2s,9ar,11s,11as)-2,11-dihydroxy-9a,11a-dimethyl-1-[(2r)-6-methylheptan-2-yl]-1h,2h,3h,3ah,3bh,4h,5h,8h,9h,9bh,10h,11h-cyclopenta[a]phenanthren-7-one

C27H44O3 (416.329)


   

(1r,3as,3bs,4r,7s,9as,9bs,11ar)-9a-(hydroxymethyl)-11a-methyl-1-[(2r,3e)-6-methylhept-3-en-2-yl]-1h,2h,3h,3ah,3bh,4h,6h,7h,8h,9h,9bh,10h,11h-cyclopenta[a]phenanthrene-4,7-diol

(1r,3as,3bs,4r,7s,9as,9bs,11ar)-9a-(hydroxymethyl)-11a-methyl-1-[(2r,3e)-6-methylhept-3-en-2-yl]-1h,2h,3h,3ah,3bh,4h,6h,7h,8h,9h,9bh,10h,11h-cyclopenta[a]phenanthrene-4,7-diol

C27H44O3 (416.329)


   

7-hydroxy-3-[2-(2-hydroxyethyl)-2-methyl-3-[(3e)-5-methylhex-3-en-2-yl]cyclopentyl]-4a-methyl-1ah,5h,6h,7h,8h-naphtho[1,8a-b]oxiren-4-one

7-hydroxy-3-[2-(2-hydroxyethyl)-2-methyl-3-[(3e)-5-methylhex-3-en-2-yl]cyclopentyl]-4a-methyl-1ah,5h,6h,7h,8h-naphtho[1,8a-b]oxiren-4-one

C26H40O4 (416.2926)


   

(4z)-3,5,5-trimethyl-4-[(2e,4e,6e,8e,10e,12e,14e)-3,7,12-trimethyl-16-oxoheptadeca-2,4,6,8,10,12,14-heptaen-1-ylidene]cyclohex-2-en-1-one

(4z)-3,5,5-trimethyl-4-[(2e,4e,6e,8e,10e,12e,14e)-3,7,12-trimethyl-16-oxoheptadeca-2,4,6,8,10,12,14-heptaen-1-ylidene]cyclohex-2-en-1-one

C29H36O2 (416.2715)


   

6,10-dimethyl-5-(6-methylheptan-2-yl)-16,17-dioxapentacyclo[13.2.2.0¹,⁹.0²,⁶.0¹⁰,¹⁵]nonadec-18-en-13-ol

6,10-dimethyl-5-(6-methylheptan-2-yl)-16,17-dioxapentacyclo[13.2.2.0¹,⁹.0²,⁶.0¹⁰,¹⁵]nonadec-18-en-13-ol

C27H44O3 (416.329)


   

(1r,5r,9r,10r,13s,14r,16r)-13-[(2r)-2-hydroxy-6-methyl-4-oxohept-5-en-2-yl]-5,9,10-trimethyl-2-oxatetracyclo[7.6.1.0⁵,¹⁶.0¹⁰,¹⁴]hexadecan-3-one

(1r,5r,9r,10r,13s,14r,16r)-13-[(2r)-2-hydroxy-6-methyl-4-oxohept-5-en-2-yl]-5,9,10-trimethyl-2-oxatetracyclo[7.6.1.0⁵,¹⁶.0¹⁰,¹⁴]hexadecan-3-one

C26H40O4 (416.2926)


   

(1s,3'r,3as,5's,5as,7s,9as,11as)-5'-[(1s)-1-hydroxypropyl]-3',3a,9a,11a-tetramethyl-3,4,5,5a,6,7,8,9,10,11-decahydro-2h-spiro[cyclopenta[a]phenanthrene-1,2'-oxolan]-7-ol

(1s,3'r,3as,5's,5as,7s,9as,11as)-5'-[(1s)-1-hydroxypropyl]-3',3a,9a,11a-tetramethyl-3,4,5,5a,6,7,8,9,10,11-decahydro-2h-spiro[cyclopenta[a]phenanthrene-1,2'-oxolan]-7-ol

C27H44O3 (416.329)


   

(1s,3as,3br,5as,9as,9bs,11as)-1-[(2s)-2-hydroxy-6-methylheptan-2-yl]-9a,11a-dimethyl-dodecahydro-1h-cyclopenta[a]phenanthrene-2,7-dione

(1s,3as,3br,5as,9as,9bs,11as)-1-[(2s)-2-hydroxy-6-methylheptan-2-yl]-9a,11a-dimethyl-dodecahydro-1h-cyclopenta[a]phenanthrene-2,7-dione

C27H44O3 (416.329)


   

(4e)-3,5,5-trimethyl-4-[(2e,4e,6e,8e,10e,12e,14e)-3,7,12-trimethyl-16-oxoheptadeca-2,4,6,8,10,12,14-heptaen-1-ylidene]cyclohex-2-en-1-one

(4e)-3,5,5-trimethyl-4-[(2e,4e,6e,8e,10e,12e,14e)-3,7,12-trimethyl-16-oxoheptadeca-2,4,6,8,10,12,14-heptaen-1-ylidene]cyclohex-2-en-1-one

C29H36O2 (416.2715)


   

(2r,6r,14r)-6-hydroxy-13-[(2s,5e)-5-isopropylhept-5-en-2-yl]-2,14-dimethyl-5-oxatetracyclo[7.7.0.0²,⁶.0¹⁰,¹⁴]hexadecan-4-one

(2r,6r,14r)-6-hydroxy-13-[(2s,5e)-5-isopropylhept-5-en-2-yl]-2,14-dimethyl-5-oxatetracyclo[7.7.0.0²,⁶.0¹⁰,¹⁴]hexadecan-4-one

C27H44O3 (416.329)


   

(1r,3as,3bs,5as,9ar,9bs,11as)-1-[(2s,3r)-3-hydroxy-6-methylheptan-2-yl]-9a,11a-dimethyl-dodecahydro-1h-cyclopenta[a]phenanthrene-5,7-dione

(1r,3as,3bs,5as,9ar,9bs,11as)-1-[(2s,3r)-3-hydroxy-6-methylheptan-2-yl]-9a,11a-dimethyl-dodecahydro-1h-cyclopenta[a]phenanthrene-5,7-dione

C27H44O3 (416.329)


   

4,15,15,19-tetramethyl-5,20-dioxapentacyclo[17.8.0.0⁴,¹³.0⁶,¹¹.0²¹,²⁶]heptacosa-6,8,10,16,21,23,25-heptaene

4,15,15,19-tetramethyl-5,20-dioxapentacyclo[17.8.0.0⁴,¹³.0⁶,¹¹.0²¹,²⁶]heptacosa-6,8,10,16,21,23,25-heptaene

C29H36O2 (416.2715)


   

9a,11a-dimethyl-1-(6-methylhept-3-en-2-yl)-1h,2h,3h,3ah,5h,6h,7h,8h,9h,9bh,10h,11h-cyclopenta[a]phenanthrene-5,5a,7-triol

9a,11a-dimethyl-1-(6-methylhept-3-en-2-yl)-1h,2h,3h,3ah,5h,6h,7h,8h,9h,9bh,10h,11h-cyclopenta[a]phenanthrene-5,5a,7-triol

C27H44O3 (416.329)


   

(1s,2r,6r,9s,10s,13r,14r)-6-hydroxy-13-[(2r,5e)-5-isopropylhept-5-en-2-yl]-2,14-dimethyl-5-oxatetracyclo[7.7.0.0²,⁶.0¹⁰,¹⁴]hexadecan-4-one

(1s,2r,6r,9s,10s,13r,14r)-6-hydroxy-13-[(2r,5e)-5-isopropylhept-5-en-2-yl]-2,14-dimethyl-5-oxatetracyclo[7.7.0.0²,⁶.0¹⁰,¹⁴]hexadecan-4-one

C27H44O3 (416.329)


   

(1r,3as,3bs,7r,9s,9ar,9bs,10r,11ar)-9a,11a-dimethyl-1-[(2r)-6-methylhept-5-en-2-yl]-1h,2h,3h,3ah,3bh,4h,6h,7h,8h,9h,9bh,10h,11h-cyclopenta[a]phenanthrene-7,9,10-triol

(1r,3as,3bs,7r,9s,9ar,9bs,10r,11ar)-9a,11a-dimethyl-1-[(2r)-6-methylhept-5-en-2-yl]-1h,2h,3h,3ah,3bh,4h,6h,7h,8h,9h,9bh,10h,11h-cyclopenta[a]phenanthrene-7,9,10-triol

C27H44O3 (416.329)


   

methyl (2e)-5-[(1s,2r,4s,4ar,8ar)-1,2,4a,5-tetramethyl-4-{[(2e)-2-methylbut-2-enoyl]oxy}-2,3,4,7,8,8a-hexahydronaphthalen-1-yl]-3-methylpent-2-enoate

methyl (2e)-5-[(1s,2r,4s,4ar,8ar)-1,2,4a,5-tetramethyl-4-{[(2e)-2-methylbut-2-enoyl]oxy}-2,3,4,7,8,8a-hexahydronaphthalen-1-yl]-3-methylpent-2-enoate

C26H40O4 (416.2926)


   

(1r,5s,5ar,7s,9ar,9bs,11ar)-9a,11a-dimethyl-1-[(2r)-6-methylhept-5-en-2-yl]-1h,2h,3h,4h,5h,6h,7h,8h,9h,9bh,10h,11h-cyclopenta[a]phenanthrene-5,5a,7-triol

(1r,5s,5ar,7s,9ar,9bs,11ar)-9a,11a-dimethyl-1-[(2r)-6-methylhept-5-en-2-yl]-1h,2h,3h,4h,5h,6h,7h,8h,9h,9bh,10h,11h-cyclopenta[a]phenanthrene-5,5a,7-triol

C27H44O3 (416.329)


   

(4e,6e,8e,10e,12e,14e,16e)-2,6,11,15-tetramethyl-17-(2,6,6-trimethylcyclohex-1-en-1-yl)heptadeca-2,4,6,8,10,12,14,16-octaenal

(4e,6e,8e,10e,12e,14e,16e)-2,6,11,15-tetramethyl-17-(2,6,6-trimethylcyclohex-1-en-1-yl)heptadeca-2,4,6,8,10,12,14,16-octaenal

C30H40O (416.3079)


   

(4as,4br,6s,6ar,9s,10as,10br,12as)-8-formyl-9-hydroxy-1,1,4a,6a,10b-pentamethyl-2,3,4,4b,5,6,9,10,10a,11,12,12a-dodecahydrochrysen-6-yl acetate

(4as,4br,6s,6ar,9s,10as,10br,12as)-8-formyl-9-hydroxy-1,1,4a,6a,10b-pentamethyl-2,3,4,4b,5,6,9,10,10a,11,12,12a-dodecahydrochrysen-6-yl acetate

C26H40O4 (416.2926)


   

(1'r,2r,2's,4's,7's,8'r,9's,10'r,12's,13'r,16's)-7',9',13'-trimethyl-5'-oxaspiro[oxane-2,6'-pentacyclo[10.8.0.0²,⁹.0⁴,⁸.0¹³,¹⁸]icosan]-18'-ene-10',16'-diol

(1'r,2r,2's,4's,7's,8'r,9's,10'r,12's,13'r,16's)-7',9',13'-trimethyl-5'-oxaspiro[oxane-2,6'-pentacyclo[10.8.0.0²,⁹.0⁴,⁸.0¹³,¹⁸]icosan]-18'-ene-10',16'-diol

C26H40O4 (416.2926)


   

(1r,2s,3as,4s,5r,7as)-4-[2-(5-hydroxy-2-methylphenyl)ethyl]-7a-methyl-1-[(2r)-6-methylheptan-2-yl]-octahydroindene-2,5-diol

(1r,2s,3as,4s,5r,7as)-4-[2-(5-hydroxy-2-methylphenyl)ethyl]-7a-methyl-1-[(2r)-6-methylheptan-2-yl]-octahydroindene-2,5-diol

C27H44O3 (416.329)


   

7-hydroxy-2-{7-hydroxy-9a,11a-dimethyl-1h,2h,3h,3ah,3bh,4h,6h,7h,8h,9h,9bh,10h,11h-cyclopenta[a]phenanthren-1-yl}-6-methylheptan-3-one

7-hydroxy-2-{7-hydroxy-9a,11a-dimethyl-1h,2h,3h,3ah,3bh,4h,6h,7h,8h,9h,9bh,10h,11h-cyclopenta[a]phenanthren-1-yl}-6-methylheptan-3-one

C27H44O3 (416.329)


   

(1r,3ar,5ar,6r,7s,9ar,9br,11ar)-1-[(2s,3r)-3-hydroxy-6-methylhept-5-en-2-yl]-9a,11a-dimethyl-1h,2h,3h,3ah,5h,5ah,6h,7h,8h,9h,9bh,10h,11h-cyclopenta[a]phenanthrene-6,7-diol

(1r,3ar,5ar,6r,7s,9ar,9br,11ar)-1-[(2s,3r)-3-hydroxy-6-methylhept-5-en-2-yl]-9a,11a-dimethyl-1h,2h,3h,3ah,5h,5ah,6h,7h,8h,9h,9bh,10h,11h-cyclopenta[a]phenanthrene-6,7-diol

C27H44O3 (416.329)


   

9a,11a-dimethyl-1-(6-methylhept-5-en-2-yl)-1h,2h,3h,4h,5h,6h,7h,8h,9h,9bh,10h,11h-cyclopenta[a]phenanthrene-5,5a,7-triol

9a,11a-dimethyl-1-(6-methylhept-5-en-2-yl)-1h,2h,3h,4h,5h,6h,7h,8h,9h,9bh,10h,11h-cyclopenta[a]phenanthrene-5,5a,7-triol

C27H44O3 (416.329)


   

(2r,6r,13s,14r)-6-hydroxy-13-[(5e)-5-isopropylhept-5-en-2-yl]-2,14-dimethyl-5-oxatetracyclo[7.7.0.0²,⁶.0¹⁰,¹⁴]hexadecan-4-one

(2r,6r,13s,14r)-6-hydroxy-13-[(5e)-5-isopropylhept-5-en-2-yl]-2,14-dimethyl-5-oxatetracyclo[7.7.0.0²,⁶.0¹⁰,¹⁴]hexadecan-4-one

C27H44O3 (416.329)


   

3,4a-dimethyl-3-(12-phenyldodecyl)-dihydro-4h-furo[3,2-c][1,2]dioxin-6-one

3,4a-dimethyl-3-(12-phenyldodecyl)-dihydro-4h-furo[3,2-c][1,2]dioxin-6-one

C26H40O4 (416.2926)


   

(1r,2s,9ar,11as)-2-hydroxy-1-[(2s,3r)-3-hydroxy-6-methylheptan-2-yl]-9a,11a-dimethyl-1h,2h,3h,3ah,3bh,4h,5h,8h,9h,9bh,10h,11h-cyclopenta[a]phenanthren-7-one

(1r,2s,9ar,11as)-2-hydroxy-1-[(2s,3r)-3-hydroxy-6-methylheptan-2-yl]-9a,11a-dimethyl-1h,2h,3h,3ah,3bh,4h,5h,8h,9h,9bh,10h,11h-cyclopenta[a]phenanthren-7-one

C27H44O3 (416.329)


   

(1r,3ar,5r,5ar,7s,9ar,9bs,11ar)-9a,11a-dimethyl-1-[(2r,3e)-6-methylhept-3-en-2-yl]-1h,2h,3h,3ah,5h,6h,7h,8h,9h,9bh,10h,11h-cyclopenta[a]phenanthrene-5,5a,7-triol

(1r,3ar,5r,5ar,7s,9ar,9bs,11ar)-9a,11a-dimethyl-1-[(2r,3e)-6-methylhept-3-en-2-yl]-1h,2h,3h,3ah,5h,6h,7h,8h,9h,9bh,10h,11h-cyclopenta[a]phenanthrene-5,5a,7-triol

C27H44O3 (416.329)


   

(4as,4br,6s,6ar,9r,10as,10br,12as)-8-formyl-9-hydroxy-1,1,4a,6a,10b-pentamethyl-2,3,4,4b,5,6,9,10,10a,11,12,12a-dodecahydrochrysen-6-yl acetate

(4as,4br,6s,6ar,9r,10as,10br,12as)-8-formyl-9-hydroxy-1,1,4a,6a,10b-pentamethyl-2,3,4,4b,5,6,9,10,10a,11,12,12a-dodecahydrochrysen-6-yl acetate

C26H40O4 (416.2926)


   

(1r,3ar,6r,7s,9ar,9br,11ar)-1-[(2s,3r)-3-hydroxy-6-methylhept-5-en-2-yl]-9a,11a-dimethyl-1h,2h,3h,3ah,5h,5ah,6h,7h,8h,9h,9bh,10h,11h-cyclopenta[a]phenanthrene-6,7-diol

(1r,3ar,6r,7s,9ar,9br,11ar)-1-[(2s,3r)-3-hydroxy-6-methylhept-5-en-2-yl]-9a,11a-dimethyl-1h,2h,3h,3ah,5h,5ah,6h,7h,8h,9h,9bh,10h,11h-cyclopenta[a]phenanthrene-6,7-diol

C27H44O3 (416.329)


   

(1as,4as,7s,8ar)-7-hydroxy-3-[(1r,2r,3r)-2-(2-hydroxyethyl)-2-methyl-3-[(2r,3e)-5-methylhex-3-en-2-yl]cyclopentyl]-4a-methyl-1ah,5h,6h,7h,8h-naphtho[1,8a-b]oxiren-4-one

(1as,4as,7s,8ar)-7-hydroxy-3-[(1r,2r,3r)-2-(2-hydroxyethyl)-2-methyl-3-[(2r,3e)-5-methylhex-3-en-2-yl]cyclopentyl]-4a-methyl-1ah,5h,6h,7h,8h-naphtho[1,8a-b]oxiren-4-one

C26H40O4 (416.2926)


   

1,3-dihydroxypropan-2-yl 3-(acetyloxy)octadecanoate

1,3-dihydroxypropan-2-yl 3-(acetyloxy)octadecanoate

C23H44O6 (416.3138)


   

(2r,6s)-2-[(1r,3as,3bs,7s,9ar,9bs,11as)-7-hydroxy-9a,11a-dimethyl-1h,2h,3h,3ah,3bh,4h,6h,7h,8h,9h,9bh,10h,11h-cyclopenta[a]phenanthren-1-yl]-7-hydroxy-6-methylheptan-3-one

(2r,6s)-2-[(1r,3as,3bs,7s,9ar,9bs,11as)-7-hydroxy-9a,11a-dimethyl-1h,2h,3h,3ah,3bh,4h,6h,7h,8h,9h,9bh,10h,11h-cyclopenta[a]phenanthren-1-yl]-7-hydroxy-6-methylheptan-3-one

C27H44O3 (416.329)


   

(1s,4r,13s,16z,19r)-4,15,15,19-tetramethyl-5,20-dioxapentacyclo[17.8.0.0⁴,¹³.0⁶,¹¹.0²¹,²⁶]heptacosa-6,8,10,16,21,23,25-heptaene

(1s,4r,13s,16z,19r)-4,15,15,19-tetramethyl-5,20-dioxapentacyclo[17.8.0.0⁴,¹³.0⁶,¹¹.0²¹,²⁶]heptacosa-6,8,10,16,21,23,25-heptaene

C29H36O2 (416.2715)


   

(1r,3ar,5as,7s,9as,9bs,11ar)-7,9b-dihydroxy-9a,11a-dimethyl-1-[(2r)-6-methylheptan-2-yl]-1h,2h,3h,3ah,5ah,6h,7h,8h,9h,10h,11h-cyclopenta[a]phenanthren-5-one

(1r,3ar,5as,7s,9as,9bs,11ar)-7,9b-dihydroxy-9a,11a-dimethyl-1-[(2r)-6-methylheptan-2-yl]-1h,2h,3h,3ah,5ah,6h,7h,8h,9h,10h,11h-cyclopenta[a]phenanthren-5-one

C27H44O3 (416.329)


   

(3r,6r)-6-[(1r,3as,7ar)-4-{2-[(5s)-5-hydroxy-2-methylidenecyclohexylidene]ethylidene}-7a-methyl-hexahydro-1h-inden-1-yl]-2-methylheptane-2,3-diol

(3r,6r)-6-[(1r,3as,7ar)-4-{2-[(5s)-5-hydroxy-2-methylidenecyclohexylidene]ethylidene}-7a-methyl-hexahydro-1h-inden-1-yl]-2-methylheptane-2,3-diol

C27H44O3 (416.329)


   

(2e,4r,7r)-4-methyl-7-(prop-1-en-2-yl)-2-{[(1r,7r,10r)-10,11,11-trimethyltricyclo[5.3.1.0¹,⁵]undec-4-en-4-yl]methylidene}-5,6,7,8-tetrahydro-4h-azulene-1-carbaldehyde

(2e,4r,7r)-4-methyl-7-(prop-1-en-2-yl)-2-{[(1r,7r,10r)-10,11,11-trimethyltricyclo[5.3.1.0¹,⁵]undec-4-en-4-yl]methylidene}-5,6,7,8-tetrahydro-4h-azulene-1-carbaldehyde

C30H40O (416.3079)


   

2,6,10,15,19,23-hexamethyltetracosa-2,4,6,8,10,12,14,16,18,22-decaenal

2,6,10,15,19,23-hexamethyltetracosa-2,4,6,8,10,12,14,16,18,22-decaenal

C30H40O (416.3079)


   

(1r,3ar,5ar,7s,9ar,9bs,11ar)-5a,7-dihydroxy-9a,11a-dimethyl-1-[(2r)-6-methylheptan-2-yl]-1h,2h,3h,3ah,6h,7h,8h,9h,9bh,10h,11h-cyclopenta[a]phenanthren-5-one

(1r,3ar,5ar,7s,9ar,9bs,11ar)-5a,7-dihydroxy-9a,11a-dimethyl-1-[(2r)-6-methylheptan-2-yl]-1h,2h,3h,3ah,6h,7h,8h,9h,9bh,10h,11h-cyclopenta[a]phenanthren-5-one

C27H44O3 (416.329)


   

1,3-dihydroxypropan-2-yl (3r)-3-(acetyloxy)octadecanoate

1,3-dihydroxypropan-2-yl (3r)-3-(acetyloxy)octadecanoate

C23H44O6 (416.3138)


   

9a,11a-dimethyl-1-(6-methylhept-5-en-2-yl)-1h,2h,3h,3ah,4h,5h,6h,7h,8h,9h,10h,11h-cyclopenta[a]phenanthrene-5,5a,7-triol

9a,11a-dimethyl-1-(6-methylhept-5-en-2-yl)-1h,2h,3h,3ah,4h,5h,6h,7h,8h,9h,10h,11h-cyclopenta[a]phenanthrene-5,5a,7-triol

C27H44O3 (416.329)


   

3-(docosa-6,9,12-trien-1-yl)-5-hydroxy-5-methylfuran-2-one

3-(docosa-6,9,12-trien-1-yl)-5-hydroxy-5-methylfuran-2-one

C27H44O3 (416.329)


   

(3s,4s,5s)-3-[(1e,3e,5s,6r)-5-hydroxy-2,6-dimethyl-7-oxoocta-1,3-dien-1-yl]-4-methyl-5-[(2e,4e,6r)-6-methyldeca-2,4-dien-2-yl]oxolan-2-one

(3s,4s,5s)-3-[(1e,3e,5s,6r)-5-hydroxy-2,6-dimethyl-7-oxoocta-1,3-dien-1-yl]-4-methyl-5-[(2e,4e,6r)-6-methyldeca-2,4-dien-2-yl]oxolan-2-one

C26H40O4 (416.2926)


   

1-(2-hydroxy-6-methylheptan-2-yl)-11a-(hydroxymethyl)-9a-methyl-1h,2h,3h,3ah,3bh,4h,5h,5ah,6h,9bh,10h,11h-cyclopenta[a]phenanthren-7-one

1-(2-hydroxy-6-methylheptan-2-yl)-11a-(hydroxymethyl)-9a-methyl-1h,2h,3h,3ah,3bh,4h,5h,5ah,6h,9bh,10h,11h-cyclopenta[a]phenanthren-7-one

C27H44O3 (416.329)


   

(1r,2s,3as,3br,5as,9ar,9bs,11as)-2-hydroxy-9a,11a-dimethyl-1-[(2r)-6-methylheptan-2-yl]-dodecahydro-1h-cyclopenta[a]phenanthrene-5,7-dione

(1r,2s,3as,3br,5as,9ar,9bs,11as)-2-hydroxy-9a,11a-dimethyl-1-[(2r)-6-methylheptan-2-yl]-dodecahydro-1h-cyclopenta[a]phenanthrene-5,7-dione

C27H44O3 (416.329)


   

methyl (1s,4s,5r,9s,10s,12s,13r)-5,9-dimethyl-12-[(3-methylbutanoyl)oxy]-14-methylidenetetracyclo[11.2.1.0¹,¹⁰.0⁴,⁹]hexadecane-5-carboxylate

methyl (1s,4s,5r,9s,10s,12s,13r)-5,9-dimethyl-12-[(3-methylbutanoyl)oxy]-14-methylidenetetracyclo[11.2.1.0¹,¹⁰.0⁴,⁹]hexadecane-5-carboxylate

C26H40O4 (416.2926)


   

4-hydroxy-3,5b,8,8,11a,13a-hexamethyl-tetradecahydrochryseno[1,2-c]furan-1,13-dione

4-hydroxy-3,5b,8,8,11a,13a-hexamethyl-tetradecahydrochryseno[1,2-c]furan-1,13-dione

C26H40O4 (416.2926)


   

4,4'-diaponeurosporenal

4,4'-diaponeurosporenal

C30H40O (416.3079)


   

2,16-dimethyl-15-(6-methylhept-5-en-2-yl)-8-oxapentacyclo[9.7.0.0²,⁷.0⁷,⁹.0¹²,¹⁶]octadecane-5,10-diol

2,16-dimethyl-15-(6-methylhept-5-en-2-yl)-8-oxapentacyclo[9.7.0.0²,⁷.0⁷,⁹.0¹²,¹⁶]octadecane-5,10-diol

C27H44O3 (416.329)


   

1-(3-hydroxy-6-methylheptan-2-yl)-9a,11a-dimethyl-dodecahydro-1h-cyclopenta[a]phenanthrene-5,7-dione

1-(3-hydroxy-6-methylheptan-2-yl)-9a,11a-dimethyl-dodecahydro-1h-cyclopenta[a]phenanthrene-5,7-dione

C27H44O3 (416.329)


   

(1r,2r,5r,10r,11r,13r,16s,20s)-17-[(1r)-1-hydroxyethyl]-10-(hydroxymethyl)-2,6,6,20-tetramethyl-14-oxapentacyclo[11.6.1.0²,¹¹.0⁵,¹⁰.0¹⁶,²⁰]icos-17-en-15-one

(1r,2r,5r,10r,11r,13r,16s,20s)-17-[(1r)-1-hydroxyethyl]-10-(hydroxymethyl)-2,6,6,20-tetramethyl-14-oxapentacyclo[11.6.1.0²,¹¹.0⁵,¹⁰.0¹⁶,²⁰]icos-17-en-15-one

C26H40O4 (416.2926)


   

(1'r,2s,2's,3s,4'r,5s,8's,9's,12'r,13's,16's,18's)-3,5,9',13'-tetramethyl-5'-oxaspiro[oxane-2,6'-pentacyclo[10.8.0.0²,⁹.0⁴,⁸.0¹³,¹⁸]icosan]-16'-ol

(1'r,2s,2's,3s,4'r,5s,8's,9's,12'r,13's,16's,18's)-3,5,9',13'-tetramethyl-5'-oxaspiro[oxane-2,6'-pentacyclo[10.8.0.0²,⁹.0⁴,⁸.0¹³,¹⁸]icosan]-16'-ol

C27H44O3 (416.329)


   

(2e)-3-(4-hydroxyphenyl)prop-2-en-1-yl octadecanoate

(2e)-3-(4-hydroxyphenyl)prop-2-en-1-yl octadecanoate

C27H44O3 (416.329)


   

1-[1-(5,5-dimethyloxolan-2-yl)ethyl]-9a,11a-dimethyl-1h,2h,3h,3ah,5h,5ah,6h,7h,8h,9h,9bh,10h,11h-cyclopenta[a]phenanthrene-6,7-diol

1-[1-(5,5-dimethyloxolan-2-yl)ethyl]-9a,11a-dimethyl-1h,2h,3h,3ah,5h,5ah,6h,7h,8h,9h,9bh,10h,11h-cyclopenta[a]phenanthrene-6,7-diol

C27H44O3 (416.329)


   

(2r)-2-[(1r,3as,3bs,5s,5as,7s,9as,11ar)-5,7-dihydroxy-9a,11a-dimethyl-1h,2h,3h,3ah,3bh,4h,5h,5ah,6h,7h,8h,9h,11h-cyclopenta[a]phenanthren-1-yl]-6-methylheptan-4-one

(2r)-2-[(1r,3as,3bs,5s,5as,7s,9as,11ar)-5,7-dihydroxy-9a,11a-dimethyl-1h,2h,3h,3ah,3bh,4h,5h,5ah,6h,7h,8h,9h,11h-cyclopenta[a]phenanthren-1-yl]-6-methylheptan-4-one

C27H44O3 (416.329)


   

3-[(1s,3ar,3br,5as,6r,9as,9bs,11as)-1-isopropyl-3b,5a,9b,11a-tetramethyl-7-oxo-dodecahydrocyclopenta[a]phenanthren-6-yl]propanoic acid

3-[(1s,3ar,3br,5as,6r,9as,9bs,11as)-1-isopropyl-3b,5a,9b,11a-tetramethyl-7-oxo-dodecahydrocyclopenta[a]phenanthren-6-yl]propanoic acid

C27H44O3 (416.329)


   

(1'r,2r,2'r,4's,5s,7'r,8's,9's,12'r,13's,16's,18'r)-5,7',9',13'-tetramethyl-5'-oxaspiro[oxane-2,6'-pentacyclo[10.8.0.0²,⁹.0⁴,⁸.0¹³,¹⁸]icosan]-16'-ol

(1'r,2r,2'r,4's,5s,7'r,8's,9's,12'r,13's,16's,18'r)-5,7',9',13'-tetramethyl-5'-oxaspiro[oxane-2,6'-pentacyclo[10.8.0.0²,⁹.0⁴,⁸.0¹³,¹⁸]icosan]-16'-ol

C27H44O3 (416.329)


   

n-(3-{[3-({4-[(3-aminopropyl)amino]butyl}amino)propyl]amino}propyl)-2-(1h-indol-2-yl)ethanimidic acid

n-(3-{[3-({4-[(3-aminopropyl)amino]butyl}amino)propyl]amino}propyl)-2-(1h-indol-2-yl)ethanimidic acid

C23H40N6O (416.3263)


   

methyl 5,9-dimethyl-12-[(3-methylbutanoyl)oxy]-14-methylidenetetracyclo[11.2.1.0¹,¹⁰.0⁴,⁹]hexadecane-5-carboxylate

methyl 5,9-dimethyl-12-[(3-methylbutanoyl)oxy]-14-methylidenetetracyclo[11.2.1.0¹,¹⁰.0⁴,⁹]hexadecane-5-carboxylate

C26H40O4 (416.2926)


   

n-[4-amino-3-({3-amino-6-[(methylamino)methyl]oxan-2-yl}oxy)-2-hydroxy-6-methoxycyclohexyl]-2-methanimidamido-n-methylacetamide

n-[4-amino-3-({3-amino-6-[(methylamino)methyl]oxan-2-yl}oxy)-2-hydroxy-6-methoxycyclohexyl]-2-methanimidamido-n-methylacetamide

C18H36N6O5 (416.2747)


   

octadecyl (2z)-3-(4-hydroxyphenyl)prop-2-enoate

octadecyl (2z)-3-(4-hydroxyphenyl)prop-2-enoate

C27H44O3 (416.329)


   

9a,11a-dimethyl-1-(6-methylhept-3-en-2-yl)-1h,2h,3h,3ah,5h,5ah,6h,7h,8h,9h,10h,11h-cyclopenta[a]phenanthrene-5,7,9b-triol

9a,11a-dimethyl-1-(6-methylhept-3-en-2-yl)-1h,2h,3h,3ah,5h,5ah,6h,7h,8h,9h,10h,11h-cyclopenta[a]phenanthrene-5,7,9b-triol

C27H44O3 (416.329)


   

4-{7-hydroxy-3a,6,6,9a,11a-pentamethyl-1h,2h,3h,3bh,4h,5h,5ah,7h,8h,9h,11h-cyclopenta[a]phenanthren-1-yl}pentanoic acid

4-{7-hydroxy-3a,6,6,9a,11a-pentamethyl-1h,2h,3h,3bh,4h,5h,5ah,7h,8h,9h,11h-cyclopenta[a]phenanthren-1-yl}pentanoic acid

C27H44O3 (416.329)


   

3,5,9',13'-tetramethyl-5'-oxaspiro[oxane-2,6'-pentacyclo[10.8.0.0²,⁹.0⁴,⁸.0¹³,¹⁸]icosan]-16'-ol

3,5,9',13'-tetramethyl-5'-oxaspiro[oxane-2,6'-pentacyclo[10.8.0.0²,⁹.0⁴,⁸.0¹³,¹⁸]icosan]-16'-ol

C27H44O3 (416.329)


   

1-(3,5-dihydroxyphenyl)henicos-3-en-2-one

1-(3,5-dihydroxyphenyl)henicos-3-en-2-one

C27H44O3 (416.329)


   

(3s,4s,5s)-3-[(1e,3e)-5-hydroxy-2,6-dimethyl-7-oxoocta-1,3-dien-1-yl]-4-methyl-5-[(2e,4e)-6-methyldeca-2,4-dien-2-yl]oxolan-2-one

(3s,4s,5s)-3-[(1e,3e)-5-hydroxy-2,6-dimethyl-7-oxoocta-1,3-dien-1-yl]-4-methyl-5-[(2e,4e)-6-methyldeca-2,4-dien-2-yl]oxolan-2-one

C26H40O4 (416.2926)


   

7-hydroxy-3-[2-(2-hydroxyethyl)-2-methyl-3-(5-methylhex-3-en-2-yl)cyclopentyl]-4a-methyl-1ah,5h,6h,7h,8h-naphtho[1,8a-b]oxiren-4-one

7-hydroxy-3-[2-(2-hydroxyethyl)-2-methyl-3-(5-methylhex-3-en-2-yl)cyclopentyl]-4a-methyl-1ah,5h,6h,7h,8h-naphtho[1,8a-b]oxiren-4-one

C26H40O4 (416.2926)


   

(4r)-4-[(1r,3as,3bs,5ar,7r,9as,11ar)-7-hydroxy-3a,6,6,9a,11a-pentamethyl-1h,2h,3h,3bh,4h,5h,5ah,7h,8h,9h,11h-cyclopenta[a]phenanthren-1-yl]pentanoic acid

(4r)-4-[(1r,3as,3bs,5ar,7r,9as,11ar)-7-hydroxy-3a,6,6,9a,11a-pentamethyl-1h,2h,3h,3bh,4h,5h,5ah,7h,8h,9h,11h-cyclopenta[a]phenanthren-1-yl]pentanoic acid

C27H44O3 (416.329)


   

2-[(1r,2r,5r)-2-[(4s,4as,6s,8as)-4,6-dihydroxy-8a-methyl-1-oxo-4,4a,5,6,7,8-hexahydronaphthalen-2-yl]-1-methyl-5-[(2r,3e)-5-methylhex-3-en-2-yl]cyclopentyl]acetaldehyde

2-[(1r,2r,5r)-2-[(4s,4as,6s,8as)-4,6-dihydroxy-8a-methyl-1-oxo-4,4a,5,6,7,8-hexahydronaphthalen-2-yl]-1-methyl-5-[(2r,3e)-5-methylhex-3-en-2-yl]cyclopentyl]acetaldehyde

C26H40O4 (416.2926)


   

n-(4-{[3-({3-[(3-aminopropyl)amino]propyl}amino)propyl]amino}butyl)-2-(1h-indol-2-yl)ethanimidic acid

n-(4-{[3-({3-[(3-aminopropyl)amino]propyl}amino)propyl]amino}butyl)-2-(1h-indol-2-yl)ethanimidic acid

C23H40N6O (416.3263)


   

4,6b,9,9,12a,14a-hexamethyl-2h,5h,6h,6ah,7h,8h,8ah,10h,11h,12h,12bh,13h,14h-phenanthro[2,1-b]oxocin-8-yl acetate

4,6b,9,9,12a,14a-hexamethyl-2h,5h,6h,6ah,7h,8h,8ah,10h,11h,12h,12bh,13h,14h-phenanthro[2,1-b]oxocin-8-yl acetate

C27H44O3 (416.329)


   

5-{7-hydroxy-3a,6,6,9a,11a-pentamethyl-dodecahydro-1h-cyclopenta[a]phenanthren-1-yl}-5-methyloxolan-2-one

5-{7-hydroxy-3a,6,6,9a,11a-pentamethyl-dodecahydro-1h-cyclopenta[a]phenanthren-1-yl}-5-methyloxolan-2-one

C27H44O3 (416.329)


   

methyl (1r,4s,5s,9s,10s,13r,15s)-5,9-dimethyl-15-[(3-methylbutanoyl)oxy]-14-methylidenetetracyclo[11.2.1.0¹,¹⁰.0⁴,⁹]hexadecane-5-carboxylate

methyl (1r,4s,5s,9s,10s,13r,15s)-5,9-dimethyl-15-[(3-methylbutanoyl)oxy]-14-methylidenetetracyclo[11.2.1.0¹,¹⁰.0⁴,⁹]hexadecane-5-carboxylate

C26H40O4 (416.2926)


   

(2s,3s)-2-[(3s,5r)-3,5-dimethyl-2-methylidene-6-{[(2s,3s)-3-(4-methylphenyl)oxiran-2-yl]methyl}hept-6-en-1-yl]-3-(4-methylphenyl)oxirane

(2s,3s)-2-[(3s,5r)-3,5-dimethyl-2-methylidene-6-{[(2s,3s)-3-(4-methylphenyl)oxiran-2-yl]methyl}hept-6-en-1-yl]-3-(4-methylphenyl)oxirane

C29H36O2 (416.2715)


   

(1r,3ar,5ar,6r,7s,9ar,9br,11ar)-1-[(1s)-1-[(2r)-5,5-dimethyloxolan-2-yl]ethyl]-9a,11a-dimethyl-1h,2h,3h,3ah,5h,5ah,6h,7h,8h,9h,9bh,10h,11h-cyclopenta[a]phenanthrene-6,7-diol

(1r,3ar,5ar,6r,7s,9ar,9br,11ar)-1-[(1s)-1-[(2r)-5,5-dimethyloxolan-2-yl]ethyl]-9a,11a-dimethyl-1h,2h,3h,3ah,5h,5ah,6h,7h,8h,9h,9bh,10h,11h-cyclopenta[a]phenanthrene-6,7-diol

C27H44O3 (416.329)


   

7,9,13-trimethyl-6-(3-methylbutyl)-5-oxapentacyclo[10.8.0.0²,⁹.0⁴,⁸.0¹³,¹⁸]icos-18-ene-14,16-diol

7,9,13-trimethyl-6-(3-methylbutyl)-5-oxapentacyclo[10.8.0.0²,⁹.0⁴,⁸.0¹³,¹⁸]icos-18-ene-14,16-diol

C27H44O3 (416.329)


   

calcitriol oral solution

calcitriol oral solution

C27H44O3 (416.329)


   

5'-(1-hydroxypropyl)-3',3a,9a,11a-tetramethyl-3,4,5,5a,6,7,8,9,10,11-decahydro-2h-spiro[cyclopenta[a]phenanthrene-1,2'-oxolan]-7-ol

5'-(1-hydroxypropyl)-3',3a,9a,11a-tetramethyl-3,4,5,5a,6,7,8,9,10,11-decahydro-2h-spiro[cyclopenta[a]phenanthrene-1,2'-oxolan]-7-ol

C27H44O3 (416.329)


   

(6as,6br,8s,8as,12ar,12br,14as)-4,6b,9,9,12a,14a-hexamethyl-2h,5h,6h,6ah,7h,8h,8ah,10h,11h,12h,12bh,13h,14h-phenanthro[2,1-b]oxocin-8-yl acetate

(6as,6br,8s,8as,12ar,12br,14as)-4,6b,9,9,12a,14a-hexamethyl-2h,5h,6h,6ah,7h,8h,8ah,10h,11h,12h,12bh,13h,14h-phenanthro[2,1-b]oxocin-8-yl acetate

C27H44O3 (416.329)


   

2-oxo-2-phenylethyl (2s)-11-cycloheptyl-2-hydroxyundecanoate

2-oxo-2-phenylethyl (2s)-11-cycloheptyl-2-hydroxyundecanoate

C26H40O4 (416.2926)


   

(3r,5as,5br,7ar,11ar,11bs,13r,13as)-13-hydroxy-11a-(hydroxymethyl)-3,5b,8,8,13a-pentamethyl-3h,4h,5h,5ah,6h,7h,7ah,9h,10h,11h,11bh,12h,13h-chryseno[1,2-c]furan-1-one

(3r,5as,5br,7ar,11ar,11bs,13r,13as)-13-hydroxy-11a-(hydroxymethyl)-3,5b,8,8,13a-pentamethyl-3h,4h,5h,5ah,6h,7h,7ah,9h,10h,11h,11bh,12h,13h-chryseno[1,2-c]furan-1-one

C26H40O4 (416.2926)


   

n-(3-{[3-({3-[(4-aminobutyl)amino]propyl}amino)propyl]amino}propyl)-2-(1h-indol-2-yl)ethanimidic acid

n-(3-{[3-({3-[(4-aminobutyl)amino]propyl}amino)propyl]amino}propyl)-2-(1h-indol-2-yl)ethanimidic acid

C23H40N6O (416.3263)


   

2-(3,5-dimethyl-2-methylidene-6-{[3-(4-methylphenyl)oxiran-2-yl]methyl}hept-6-en-1-yl)-3-(4-methylphenyl)oxirane

2-(3,5-dimethyl-2-methylidene-6-{[3-(4-methylphenyl)oxiran-2-yl]methyl}hept-6-en-1-yl)-3-(4-methylphenyl)oxirane

C29H36O2 (416.2715)


   

(1'r,2r,2'r,4'r,5r,7's,8'r,9's,12's,13's,16's,18's)-5,7',9',13'-tetramethyl-5'-oxaspiro[oxane-2,6'-pentacyclo[10.8.0.0²,⁹.0⁴,⁸.0¹³,¹⁸]icosan]-16'-ol

(1'r,2r,2'r,4'r,5r,7's,8'r,9's,12's,13's,16's,18's)-5,7',9',13'-tetramethyl-5'-oxaspiro[oxane-2,6'-pentacyclo[10.8.0.0²,⁹.0⁴,⁸.0¹³,¹⁸]icosan]-16'-ol

C27H44O3 (416.329)


   

(1r,2r,4s,6r,7s,8r,9s,12r,13r,14r,16s)-7,9,13-trimethyl-6-(3-methylbutyl)-5-oxapentacyclo[10.8.0.0²,⁹.0⁴,⁸.0¹³,¹⁸]icos-18-ene-14,16-diol

(1r,2r,4s,6r,7s,8r,9s,12r,13r,14r,16s)-7,9,13-trimethyl-6-(3-methylbutyl)-5-oxapentacyclo[10.8.0.0²,⁹.0⁴,⁸.0¹³,¹⁸]icos-18-ene-14,16-diol

C27H44O3 (416.329)


   

methyl 5-{1,2,4a,5-tetramethyl-4-[(2-methylbut-2-enoyl)oxy]-2,3,4,7,8,8a-hexahydronaphthalen-1-yl}-3-methylpent-2-enoate

methyl 5-{1,2,4a,5-tetramethyl-4-[(2-methylbut-2-enoyl)oxy]-2,3,4,7,8,8a-hexahydronaphthalen-1-yl}-3-methylpent-2-enoate

C26H40O4 (416.2926)


   

1-(2,6-dihydroxy-6-methylheptan-2-yl)-9a,11a-dimethyl-1h,2h,3h,3ah,3bh,4h,5h,8h,9h,9bh,10h,11h-cyclopenta[a]phenanthren-7-one

1-(2,6-dihydroxy-6-methylheptan-2-yl)-9a,11a-dimethyl-1h,2h,3h,3ah,3bh,4h,5h,8h,9h,9bh,10h,11h-cyclopenta[a]phenanthren-7-one

C27H44O3 (416.329)


   

3,5,5-trimethyl-4-(3,7,12-trimethyl-16-oxoheptadeca-2,4,6,8,10,12,14-heptaen-1-ylidene)cyclohex-2-en-1-one

3,5,5-trimethyl-4-(3,7,12-trimethyl-16-oxoheptadeca-2,4,6,8,10,12,14-heptaen-1-ylidene)cyclohex-2-en-1-one

C29H36O2 (416.2715)


   

5a,7-dihydroxy-9a,11a-dimethyl-1-(6-methylheptan-2-yl)-1h,2h,3h,3ah,6h,7h,8h,9h,9bh,10h,11h-cyclopenta[a]phenanthren-5-one

5a,7-dihydroxy-9a,11a-dimethyl-1-(6-methylheptan-2-yl)-1h,2h,3h,3ah,6h,7h,8h,9h,9bh,10h,11h-cyclopenta[a]phenanthren-5-one

C27H44O3 (416.329)


   

9a,11a-dimethyl-1-(6-methylhept-5-en-2-yl)-1h,2h,3h,3ah,3bh,4h,6h,7h,8h,9h,9bh,10h,11h-cyclopenta[a]phenanthrene-7,9,10-triol

9a,11a-dimethyl-1-(6-methylhept-5-en-2-yl)-1h,2h,3h,3ah,3bh,4h,6h,7h,8h,9h,9bh,10h,11h-cyclopenta[a]phenanthrene-7,9,10-triol

C27H44O3 (416.329)


   

(3s,3as,4s,5as,5br,7as,11as,11br,13as,13bs)-4-hydroxy-3,5b,8,8,11a,13a-hexamethyl-tetradecahydrochryseno[1,2-c]furan-1,13-dione

(3s,3as,4s,5as,5br,7as,11as,11br,13as,13bs)-4-hydroxy-3,5b,8,8,11a,13a-hexamethyl-tetradecahydrochryseno[1,2-c]furan-1,13-dione

C26H40O4 (416.2926)


   

(5s)-5-[(1r,3ar,3br,5ar,7s,9ar,9br,11as)-7-hydroxy-3a,3b,6,6,9a-pentamethyl-dodecahydro-1h-cyclopenta[a]phenanthren-1-yl]-5-methyloxolan-2-one

(5s)-5-[(1r,3ar,3br,5ar,7s,9ar,9br,11as)-7-hydroxy-3a,3b,6,6,9a-pentamethyl-dodecahydro-1h-cyclopenta[a]phenanthren-1-yl]-5-methyloxolan-2-one

C27H44O3 (416.329)


   

1β-calcitriol

1β-calcitriol

C27H44O3 (416.329)


   

2-{5,7-dihydroxy-9a,11a-dimethyl-1h,2h,3h,3ah,3bh,4h,5h,5ah,6h,7h,8h,9h,11h-cyclopenta[a]phenanthren-1-yl}-6-methylheptan-4-one

2-{5,7-dihydroxy-9a,11a-dimethyl-1h,2h,3h,3ah,3bh,4h,5h,5ah,6h,7h,8h,9h,11h-cyclopenta[a]phenanthren-1-yl}-6-methylheptan-4-one

C27H44O3 (416.329)


   

methyl (2e)-5-[(1s,2r,4r,4ar,8ar)-1,2,4a,5-tetramethyl-4-{[(2z)-2-methylbut-2-enoyl]oxy}-2,3,4,7,8,8a-hexahydronaphthalen-1-yl]-3-methylpent-2-enoate

methyl (2e)-5-[(1s,2r,4r,4ar,8ar)-1,2,4a,5-tetramethyl-4-{[(2z)-2-methylbut-2-enoyl]oxy}-2,3,4,7,8,8a-hexahydronaphthalen-1-yl]-3-methylpent-2-enoate

C26H40O4 (416.2926)


   

(5r)-3-[(6z,9z,12z)-docosa-6,9,12-trien-1-yl]-5-hydroxy-5-methylfuran-2-one

(5r)-3-[(6z,9z,12z)-docosa-6,9,12-trien-1-yl]-5-hydroxy-5-methylfuran-2-one

C27H44O3 (416.329)


   

(1s,2r,5r,6r,9r,10r,13s,15s)-6,10-dimethyl-5-[(2r)-6-methylheptan-2-yl]-16,17-dioxapentacyclo[13.2.2.0¹,⁹.0²,⁶.0¹⁰,¹⁵]nonadec-18-en-13-ol

(1s,2r,5r,6r,9r,10r,13s,15s)-6,10-dimethyl-5-[(2r)-6-methylheptan-2-yl]-16,17-dioxapentacyclo[13.2.2.0¹,⁹.0²,⁶.0¹⁰,¹⁵]nonadec-18-en-13-ol

C27H44O3 (416.329)


   

(3r)-6-[(4e,7ar)-4-{2-[(1z,5s)-5-hydroxy-2-methylidenecyclohexylidene]ethylidene}-7a-methyl-hexahydro-1h-inden-1-yl]-2-methylheptane-2,3-diol

(3r)-6-[(4e,7ar)-4-{2-[(1z,5s)-5-hydroxy-2-methylidenecyclohexylidene]ethylidene}-7a-methyl-hexahydro-1h-inden-1-yl]-2-methylheptane-2,3-diol

C27H44O3 (416.329)


   

(1s,3as,3br,5as,9ar,9bs,11ar)-1-[(2s)-2-hydroxy-6-methylheptan-2-yl]-11a-(hydroxymethyl)-9a-methyl-1h,2h,3h,3ah,3bh,4h,5h,5ah,6h,9bh,10h,11h-cyclopenta[a]phenanthren-7-one

(1s,3as,3br,5as,9ar,9bs,11ar)-1-[(2s)-2-hydroxy-6-methylheptan-2-yl]-11a-(hydroxymethyl)-9a-methyl-1h,2h,3h,3ah,3bh,4h,5h,5ah,6h,9bh,10h,11h-cyclopenta[a]phenanthren-7-one

C27H44O3 (416.329)


   

2-hydroxy-9a,11a-dimethyl-1-(6-methylheptan-2-yl)-dodecahydro-1h-cyclopenta[a]phenanthrene-5,7-dione

2-hydroxy-9a,11a-dimethyl-1-(6-methylheptan-2-yl)-dodecahydro-1h-cyclopenta[a]phenanthrene-5,7-dione

C27H44O3 (416.329)